Contact Molecules for Homologous Proteins | ||||
[Full Bars] |
[SiteTable] |
|
[Back to Search Page] |
[Back to HOMCOS] |
[SupCon3D] |
[help] |
seq_id(%): [0] [30] [40] [50] [60] [70] [80] [90] [95] [100] | [show] [download] [help] |
PID | QueryLength | Homolgous Sequence in PDB | UniProt Query | TITLE |
4085421 | 437 | 500 | Q9NRS4(TMPS4_HUMAN) | RecName: Full=Transmembrane protease serine 4 ; EC=3.4.21.-;AltName: Full=Channel-activating protease 2; Short=CAPH2;AltName: Full=Membrane-type serine protease 2; Short=MT-SP2;Contains: RecName: Full=Transmembrane protease serine 4 catalytic chain; |
QUERYSEQ |
MLQDPDSDQPLNSLDVKPLRKPRIPMETFRKVGIPIIIALLSLASIIIVVVLIKVILDKYYFLCGQPLHFIPRKQLCDGELDCPLGEDEEHCVKSFPEGPAVAVRLSKDRSTLQVLDSATGNWFSACFDNFTEALAETACRQMGYSSKPT FRAVEIGPDQDLDVVEITENSQELRMRNSSGPCLSGSLVSLHCLACGKSLKTPRVVGVEEASVDSWPWQVSIQYDKQHVCGGSILDPHWVLTAAHCFRKHTDVFNWKVRAGSDKLGSFPSLAVAKIIIIEFNPMYPKDNDIALMKLQFPL TFSGTVRPICLPFFDEELTPATPLWIIGWGFTKQNGGKMSDILLQASVQVIDSTRCNADDAYQGEVTEKMMCAGIPEGGVDTCQGDSGGPLMYQSDQWHVVGIVSWGYGCGGPSTPGVYTKVSAYLNWIYNVWKAEL |
437 | region | name | description |
1-437 | CHAIN | /note="Transmembrane protease serine 4" /id="PRO_0000088692" | |
0-437 | CHAIN | /note="Transmembrane protease serine 4 catalytic chain" /id="PRO_0000451627" | |
1-32 | TOPO_DOM | /note="Cytoplasmic" | |
33-53 | TRANSMEM | /note="Helical; Signal-anchor for type II membrane protein" | |
54-437 | TOPO_DOM | /note="Extracellular" | |
61-93 | DOMAIN | /note="LDL-receptor class A" | |
94-204 | DOMAIN | /note="SRCR" | |
205-434 | DOMAIN | /note="Peptidase S1" | |
245-245 | ACT_SITE | /note="Charge relay system" | |
290-290 | ACT_SITE | /note="Charge relay system" | |
387-387 | ACT_SITE | /note="Charge relay system" | |
1-437 | DISORDER | predicted by DISOPRED |
MONOMER | |||||||
437 | |||||||
pdb_id | a1 | identity[%]2 | description | ||||
8yoy | B | 42.5 | TMPS2_HUMAN Transmembrane protease serine 2 | ||||
1.a1:asym_id for the homologue. 2.identity[%]2:sequence identity between the query and the homologue. |
HETERO | |||||||
437 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
1fiw[1] | B | BETA-ACROSIN LIGHT CHAIN[14 aa] | A | 28.6 /46.9 |
21 /24 |
ACRO_SHEEP BETA-ACROSIN HEAVY CHAIN | |
6a8o[1] | C | peptide inhibitor,[10 aa] | A | 0.0 /45.9 |
1 /4 |
KLKB1_MOUSE Plasma kallikrein | |
6a8o[1] | C | peptide inhibitor,[10 aa] | B | 50.0 /45.9 |
14 /14 |
KLKB1_MOUSE Plasma kallikrein | |
6kd5[1] | A | TMPSD_HUMAN Transmembrane protease serine 13[131 aa] | B | 36.8 /45.4 |
38 /45 |
TMPSD_HUMAN Transmembrane protease serine 13 | |
6kd5[1] | C | DECANOYL-ARG-VAL-LYS-ARG-CHLOROMETHYLKETONE INHIBI.. | B | 65.0 /45.4 |
20 /20 |
TMPSD_HUMAN Transmembrane protease serine 13 | |
1gl1[3] | D | LCM_LOCMI PROTEASE INHIBITOR LCMI II[34 aa] | A | 63.2 /45.3 |
19 /21 |
CTRA_BOVIN ALPHA-CHYMOTRYPSIN | |
1fiz[2] | B | ACRO_PIG BETA-ACROSIN LIGHT CHAIN[13 aa] | A | 23.8 /45.1 |
21 /24 |
ACRO_PIG BETA-ACROSIN HEAVY CHAIN | |
1acb[1] | B | ICIC_HIRME Eglin C[63 aa] | A | 58.8 /45.1 |
17 /19 |
CTRA_BOVIN ALPHA-CHYMOTRYPSIN | |
1oxg[1] | B | CTRA_BOVIN Chymotrypsinogen A[14 aa] | A | 56.2 /45.1 |
16 /16 |
CTRA_BOVIN Chymotrypsinogen A | |
3t62[3] | B | ISH1_STOHE Kunitz-type proteinase inhibitor SHPI-1[54 aa] | A | 52.4 /45.1 |
21 /22 |
CTRA_BOVIN Chymotrypsinogen A | |
1cgi[2] | B | IPK1_HUMAN PANCREATIC SECRETORY TRYPSIN INHIBITOR (KAZAL TYPE.. | A | 42.3 /44.9 |
26 /29 |
CTRA_BOVIN ALPHA-CHYMOTRYPSINOGEN | |
2y6t[4] | E | ECOT_YERPY ECOTIN[141 aa] | A | 57.1 /44.9 |
21 /26 |
CTRA_BOVIN CHYMOTRYPSINOGEN A | |
2y6t[4] | F | ECOT_YERPY ECOTIN[142 aa] | A | 45.5 /44.9 |
11 /12 |
CTRA_BOVIN CHYMOTRYPSINOGEN A | |
1dlk[3] | A | CTRA_BOVIN Thrombin light chain[13 aa] | B | 55.6 /44.7 |
18 /19 |
CTRA_BOVIN Thrombin heavy chain | |
1dlk[3] | E | peptidic inhibitor[5 aa] | B | 63.6 /44.7 |
11 /14 |
CTRA_BOVIN Thrombin heavy chain | |
1dlk[2] | F | peptidic inhibitor[5 aa] | B | 0.0 /44.7 |
2 /2 |
CTRA_BOVIN Thrombin heavy chain | |
1gl0[1] | B | LCM_LOCMI PROTEASE INHIBITOR LCMI I[32 aa] | A | 54.5 /44.7 |
22 /26 |
CTRA_BOVIN CHYMOTRYPSINOGEN A | |
5j4q[1] | B | IBB1_SOYBN Bowman-Birk type proteinase inhibitor[64 aa] | A | 40.9 /44.7 |
22 /24 |
CTRA_BOVIN Chymotrypsinogen A | |
5j4s[1] | B | IBB1_SOYBN Bowman-Birk type proteinase inhibitor[67 aa] | A | 55.0 /44.7 |
20 /23 |
CTRA_BOVIN Chymotrypsinogen A | |
7xyd[4] | A | TMPS2_HUMAN Transmembrane protease serine 2 catalytic chain[12.. | B | 28.0 /44.2 |
25 /28 |
TMPS2_HUMAN Transmembrane protease serine 2 catalytic chain | |
7xyd[2] | C | TMPS2_HUMAN Transmembrane protease serine 2 catalytic chain[12.. | D | 29.6 /44.2 |
27 /29 |
TMPS2_HUMAN Transmembrane protease serine 2 catalytic chain | |
7y0e[2] | C | TMPS2_HUMAN Transmembrane protease serine 2 catalytic chain[13.. | D | 33.3 /44.2 |
27 /29 |
TMPS2_HUMAN Transmembrane protease serine 2 catalytic chain | |
8v04[3] | A | TMPS2_HUMAN Transmembrane protease serine 2 non-catalytic chai.. | B | 30.4 /44.2 |
23 /24 |
TMPS2_HUMAN Transmembrane protease serine 2 | |
8y1d[13] | A | SPIKE_CVHN2 Spike glycoprotein[1208 aa] | D | 33.3 /41.8 |
12 /13 |
TMPS2_HUMAN Transmembrane protease serine 2 | |
8y7x[3] | B | SPIKE_CVHN1 Spike glycoprotein[1197 aa] | D | 25.0 /44.2 |
12 /13 |
TMPS2_HUMAN Transmembrane protease serine 2 | |
8vis[1] | A | TM11D_HUMAN Transmembrane protease serine 11D non-catalytic ch.. | B | 40.0 /43.7 |
15 /17 |
TM11D_HUMAN Transmembrane protease serine 11D catalytic chain | |
8vis[3] | C | TM11D_HUMAN Transmembrane protease serine 11D non-catalytic ch.. | D | 46.2 /43.7 |
13 /15 |
TM11D_HUMAN Transmembrane protease serine 11D catalytic chain | |
4ogx[2] | B | DX-2930 HEAVY CHAIN[216 aa] | A | 48.1 /43.2 |
27 /29 |
KLKB1_HUMAN Plasma kallikrein | |
4ogy[1] | E | DX-2930 HEAVY CHAIN[200 aa] | B | 55.6 /43.2 |
18 /19 |
KLKB1_HUMAN Plasma kallikrein | |
1pyt[1] | A | CBPA1_BOVIN PROCARBOXYPEPTIDASE A[94 aa] | D | 20.0 /43.2 |
10 /10 |
CHYMOTRYPSINOGEN C | |
1pyt[1] | B | CBPA1_BOVIN PROCARBOXYPEPTIDASE A[309 aa] | D | 22.2 /43.2 |
9 /10 |
CHYMOTRYPSINOGEN C | |
8fgx[1] | A | STAR-0215 Light chain[213 aa] | C | 37.5 /43.1 |
8 /8 |
KLKB1_HUMAN Plasma kallikrein light chain | |
8fgx[1] | B | STAR-0215 Heavy chain[216 aa] | C | 41.7 /43.1 |
12 /13 |
KLKB1_HUMAN Plasma kallikrein light chain | |
1o5e[3] | A | HEPS_HUMAN Serine protease hepsin[110 aa] | B | 32.3 /42.9 |
31 /31 |
HEPS_HUMAN Serine protease hepsin | |
3bn9[2] | B | E2 Fab Light Chain[210 aa] | A | 0.0 /39.6 |
2 /3 |
ST14_HUMAN Membrane-type serine protease 1 | |
4ogx[3] | C | DX-2930 LIGHT CHAIN[212 aa] | A | 0.0 /43.2 |
5 /6 |
KLKB1_HUMAN Plasma kallikrein | |
6aod[1] | A | FXIa Antibody FAB Light Chain[207 aa] | C | 52.0 /39.6 |
25 /26 |
FA11_HUMAN Coagulation factor XI | |
6hhc[1] | A | FXIA ANTIBODY FAB LIGHT CHAIN[213 aa] | C | 14.3 /42.9 |
7 /7 |
FA11_HUMAN Coagulation factor XI | |
6hhc[1] | B | FXIA ANTIBODY FAB HEAVY CHAIN[214 aa] | C | 18.2 /42.9 |
11 /13 |
FA11_HUMAN Coagulation factor XI | |
5f8t[1] | B | CYS-PRO-LYS-ARG-PHE-M70-ALA-LEU-PHE-CYS[10 aa] | A | 52.9 /42.8 |
17 /18 |
KLKB1_HUMAN Plasma kallikrein light chain | |
5f8x[1] | B | CYS-PRO-ALA-ARG-PHE-M70-ALA-LEU-TRP-CYS[10 aa] | A | 55.6 /42.8 |
18 /19 |
KLKB1_HUMAN Plasma kallikrein | |
5f8z[1] | B | CYS-PRO-ALA-ARG-PHE-M70-ALA-LEU-PHE-CYS[10 aa] | A | 60.0 /42.8 |
15 /16 |
KLKB1_HUMAN Plasma kallikrein LIGHT CHAIN | |
3e0n[1] | B | DPN-PHE-ARM[3 aa] | A | 76.5 /42.7 |
17 /20 |
PRSS8_HUMAN Prostasin heavy chain | |
8s0m[4] | D | SPIKE_CVHN5 Spike protein S1[346 aa] | A | 12.5 /41.2 |
16 /17 |
TMPS2_HUMAN Transmembrane protease serine 2 | |
8vgt[1] | A | SPIKE_CVHN1 Spike protein S1[280 aa] | B | 20.0 /41.0 |
15 /15 |
TMPS2_HUMAN Transmembrane protease serine 2 | |
8y7y[2] | C | SPIKE_CVHN1 Spike glycoprotein[354 aa] | B | 27.3 /44.2 |
11 /12 |
TMPS2_HUMAN Transmembrane protease serine 2 | |
8jhz[1] | A | M9ZTT7_PAESO Hemorrhagic toxin[2615 aa] | B | 43.8 /42.4 |
16 /17 |
TMPS2_HUMAN Transmembrane protease serine 2 | |
8ji0[1] | B | MALE_ECOLI M9ZTT7_PAESO Maltose/maltodextrin-binding periplasmic protein,H.. | A | 43.8 /42.4 |
16 /17 |
TMPS2_HUMAN Transmembrane protease serine 2 | |
1xx9[6] | C | ECOT_ECOLI Ecotin[140 aa] | A | 61.5 /41.9 |
26 /27 |
FA11_HUMAN Coagulation factor XI | |
1xx9[6] | D | ECOT_ECOLI Ecotin[139 aa] | A | 25.0 /41.9 |
12 /13 |
FA11_HUMAN Coagulation factor XI | |
6r8x[1] | B | anti-Factor-XI Fab fragment light chain MAA868[211.. | A | 20.0 /42.1 |
5 /7 |
FA11_HUMAN Coagulation factor XI | |
6r8x[1] | C | anti-Factor-XI Fab fragment heavy chain MAA868[219.. | A | 42.9 /42.1 |
14 /15 |
FA11_HUMAN Coagulation factor XI | |
1taw[2] | B | A4_HUMAN PROTEASE INHIBITOR DOMAIN OF ALZHEIMER'S AMYLOID B.. | A | 75.0 /40.7 |
20 /21 |
TRY1_BOVIN TRYPSIN | |
1zjd[1] | B | A4_HUMAN Kunitz Protease Inhibitory Domain of Protease Nexi.. | A | 61.9 /41.9 |
21 /22 |
FA11_HUMAN Catalytic Domain of Coagulation Factor XI | |
4ty6[4] | B | FA11_HUMAN CYS-THR-THR-LYS-ILE-LYS-PRO[7 aa] | A | 44.4 /41.9 |
9 /13 |
FA11_HUMAN Coagulation factor XI | |
5q0f[1] | B | MET-ASP-ASP-ASP-ASP-LYS-MET-ASP-ASN-GLU-CYS-THR-TH.. | A | 50.0 /41.9 |
8 /11 |
FA11_HUMAN Coagulation factor XI | |
5qtx[1] | B | FA11_HUMAN Coagulation factor XI[6 aa] | A | 50.0 /41.9 |
8 /11 |
FA11_HUMAN Coagulation factor XI | |
6twb[1] | C | Double Bridged Peptide F19[11 aa] | A | 65.0 /41.9 |
20 /21 |
FA11_HUMAN Coagulation factor XI | |
6twc[1] | B | FA11_HUMAN Coagulation factor XI[8 aa] | A | 42.9 /41.9 |
7 /10 |
FA11_HUMAN Coagulation factor XI | |
6twc[1] | C | Double Bridged Peptide F21[12 aa] | A | 70.0 /41.9 |
20 /22 |
FA11_HUMAN Coagulation factor XI | |
1bzx[57] | B | BPT1_BOVIN PROTEIN (BOVINE PANCREATIC TRYPSIN INHIBITOR)[58 a.. | A | 70.0 /40.5 |
20 /20 |
TRY1_SALSA PROTEIN (TRYPSIN) | |
1p2n[12] | D | BPT1_BOVIN Pancreatic trypsin inhibitor[58 aa] | A | 25.0 /45.1 |
4 /5 |
CTRA_BOVIN Chymotrypsinogen A | |
2ptc[4] | B | BPT1_BOVIN TRYPSIN INHIBITOR[58 aa] | A | 11.1 /40.7 |
9 /9 |
TRY1_BOVIN BETA-TRYPSIN | |
2ptc[4] | B | BPT1_BOVIN TRYPSIN INHIBITOR[58 aa] | A | 0.0 /40.7 |
2 /3 |
TRY1_BOVIN BETA-TRYPSIN | |
4bnr[2] | C | BPT1_BOVIN PANCREATIC TRYPSIN INHIBITOR[59 aa] | A | 63.6 /41.6 |
22 /22 |
Q52V24_PONLE HEPATOPANCREAS TRYPSIN | |
2f91[1] | B | SGP1_SCHGR Serine protease inhibitor I/II[33 aa] | A | 64.3 /41.6 |
28 /28 |
Q52V24_PONLE hepatopancreas trypsin | |
8s0l[3] | B | Nanobody A07[130 aa] | A | 53.1 /42.6 |
32 /35 |
TMPS2_HUMAN Transmembrane protease serine 2 | |
3myw[2] | B | IBB_PHAAU Bowman-Birk type trypsin inhibitor[55 aa] | A | 73.9 /41.5 |
23 /23 |
TRYP_PIG Trypsin | |
8s0m[2] | C | Nanobody A01[131 aa] | A | 17.2 /41.2 |
29 /29 |
TMPS2_HUMAN Transmembrane protease serine 2 | |
4doq[2] | B | SLPI_HUMAN Antileukoproteinase[47 aa] | A | 56.5 /41.4 |
23 /23 |
TRYP_PIG Trypsin | |
5xwj[4] | B | Acetylated-THR-ARG-GLU Inhibitor[3 aa] | A | 86.7 /41.0 |
15 /15 |
TRYP_PIG Trypsin | |
1an1[2] | B | LDTI_HIRME TRYPTASE INHIBITOR[40 aa] | A | 80.0 /41.2 |
20 /20 |
TRYP_PIG TRYPSIN | |
1avw[2] | B | ITRA_SOYBN TRYPSIN INHIBITOR[171 aa] | A | 64.0 /41.0 |
25 /25 |
TRYP_PIG TRYPSIN | |
1c9p[2] | B | BDEL_HIRME BDELLASTASIN[50 aa] | A | 78.9 /41.2 |
19 /19 |
TRYP_PIG TRYPSIN | |
1h9i[1] | B | ITR2_ECBEL TRYPSIN INHIBITOR II[30 aa] | A | 72.7 /41.0 |
22 /22 |
TRYP_PIG TRYPSIN | |
1tfx[2] | C | TFPI1_HUMAN TISSUE FACTOR PATHWAY INHIBITOR[58 aa] | A | 68.4 /41.0 |
19 /19 |
TRYP_PIG TRYPSIN | |
1tx6[4] | E | IBB_HORVU Bowman-Birk type trypsin inhibitor[110 aa] | A | 53.8 /41.0 |
26 /26 |
TRYP_PIG Trypsin | |
1v6d[1] | B | PD(AIB)L(AIB)LA[7 aa] | A | 0.0 /41.0 |
3 /4 |
TRYP_PIG Trypsin | |
1yf4[1] | B | Vasopressin[10 aa] | A | 69.6 /41.0 |
23 /23 |
TRYP_PIG Trypsin | |
1z7k[1] | B | IOVO_MELGA Ovomucoid[62 aa] | A | 66.7 /41.0 |
24 /24 |
TRYP_PIG Trypsin | |
4an7[1] | B | F4ZZG4_TAMIN TRYPSIN INHIBITOR[156 aa] | A | 66.7 /41.0 |
24 /24 |
TRYP_PIG TRYPSIN | |
1tps[1] | B | INHIBITOR A90720A[8 aa] | A | 78.9 /40.7 |
19 /20 |
TRY1_BOVIN TRYPSIN | |
1zr0[2] | B | TFPI2_HUMAN Tissue factor pathway inhibitor 2[63 aa] | A | 73.7 /40.7 |
19 /20 |
TRY1_BOVIN Cationic trypsin | |
2age[2] | B | succinyl-Ala-Ala-Pro-Arg[4 aa] | A | 87.5 /40.7 |
16 /16 |
TRY1_BOVIN Cationic trypsin | |
2qyi[1] | B | ICW3_PSOTE Chymotrypsin inhibitor 3[175 aa] | C | 0.0 /40.7 |
1 /1 |
TRY1_BOVIN Cationic trypsin | |
2qyi[1] | D | ICW3_PSOTE Chymotrypsin inhibitor 3[175 aa] | C | 66.7 /40.7 |
24 /26 |
TRY1_BOVIN Cationic trypsin | |
4abi[1] | B | SFTI1_HELAN PTA-SFTI INHIBITOR[11 aa] | A | 68.2 /40.7 |
22 /23 |
TRY1_BOVIN CATIONIC TRYPSIN | |
8uo7[1] | B | Deacetylated wildtype microviridin J[12 aa] | A | 75.0 /40.7 |
20 /22 |
TRY1_BOVIN Cationic trypsin | |
8utl[1] | B | Thr3Dap mutated microviridin J[12 aa] | A | 75.0 /40.7 |
20 /22 |
TRY1_BOVIN Cationic trypsin | |
1mct[1] | B | ITRA_MOMCH TRYPSIN INHIBITOR A[28 aa] | A | 72.7 /40.6 |
22 /22 |
TRYP_PIG BETA-TRYPSIN | |
1tgs[1] | B | IPK1_PIG PANCREATIC SECRETORY TRYPSIN INHIBITOR (KAZAL TYPE.. | A | 58.3 /40.5 |
24 /25 |
TRY1_BOVIN TRYPSINOGEN | |
2sta[1] | B | ITR1_CUCMA PROTEIN (TRYPSIN INHIBITOR)[29 aa] | A | 84.2 /40.5 |
19 /19 |
TRY1_SALSA PROTEIN (TRYPSIN) | |
2stb[1] | B | ITR3_CUCPE PROTEIN (TRYPSIN INHIBITOR)[29 aa] | A | 75.0 /40.5 |
20 /20 |
TRY1_SALSA PROTEIN (TRYPSIN) | |
1bml[2] | C | STRP_STREQ STREPTOKINASE[318 aa] | A | 12.9 /40.3 |
31 /34 |
PLMN_HUMAN PLASMIN | |
1bml[2] | D | STRP_STREQ STREPTOKINASE[318 aa] | A | 0.0 /40.3 |
1 /1 |
PLMN_HUMAN PLASMIN | |
1bui[1] | C | SAK_BPP42 Staphylokinase[122 aa] | A | 21.4 /40.3 |
14 /14 |
PLMN_HUMAN Plasminogen | |
1bui[1] | C | SAK_BPP42 Staphylokinase[122 aa] | B | 7.7 /40.3 |
13 /14 |
PLMN_HUMAN Plasminogen | |
1l4d[4] | B | STRP_STREQ STREPTOKINASE[112 aa] | A | 35.7 /40.3 |
14 /16 |
PLMN_HUMAN PLASMINOGEN | |
1l4d[2] | B | STRP_STREQ STREPTOKINASE[112 aa] | A | 50.0 /40.3 |
16 /17 |
PLMN_HUMAN PLASMINOGEN | |
1l4z[2] | B | STRP_STREQ Streptokinase[125 aa] | A | 16.7 /40.3 |
6 /6 |
PLMN_HUMAN Plasminogen | |
3uir[2] | C | IVBI1_PSETT Textilinin-1[56 aa] | A | 78.9 /40.3 |
19 /19 |
PLMN_HUMAN Plasmin light chain B | |
6d3x[2] | C | SFTI1_HELAN Trypsin inhibitor 1[14 aa] | A | 73.7 /40.3 |
19 /19 |
PLMN_HUMAN Plasminogen | |
6d3y[1] | B | SFTI1_HELAN Trypsin inhibitor 1[14 aa] | A | 68.4 /40.3 |
19 /19 |
PLMN_HUMAN Plasminogen | |
6d40[1] | B | SFTI1_HELAN Trypsin inhibitor 1[14 aa] | A | 77.8 /40.3 |
18 /18 |
PLMN_HUMAN Plasminogen | |
6q1u[2] | C | GLY-ARG-ALA-TYR-LYS-SER-LYS-PRO-PRO-ILE-ALA-PHE-PR.. | A | 76.5 /40.3 |
17 /17 |
PLMN_HUMAN Plasminogen | |
7e50[1] | A | Q1HRB8_AEDAE AAEL006007-PA[55 aa] | B | 78.9 /40.3 |
19 /19 |
PLMN_HUMAN Plasminogen | |
3p8f[1] | B | SFTI1_HELAN Trypsin inhibitor 1[14 aa] | A | 70.0 /40.1 |
20 /23 |
Q8WVC1_HUMAN ST14 protein | |
4isl[3] | A | SPIT1_HUMAN Kunitz-type protease inhibitor 1[60 aa] | B | 64.0 /39.6 |
25 /29 |
ST14_HUMAN Suppressor of tumorigenicity 14 protein | |
4o97[3] | B | ST14_HUMAN Peptide CGLR[4 aa] | A | 54.5 /40.1 |
11 /11 |
ST14_HUMAN Suppressor of tumorigenicity 14 protein | |
6d3z[1] | B | SFTI1_HELAN Trypsin inhibitor 1[14 aa] | A | 65.0 /39.9 |
20 /20 |
PLMN_HUMAN Plasminogen | |
3so3[1] | B | A11 FAB light chain[216 aa] | A | 12.5 /39.8 |
8 /10 |
ST14_HUMAN Suppressor of tumorigenicity 14 protein | |
3so3[1] | C | A11 FAB heavy chain[220 aa] | A | 58.3 /39.8 |
12 /18 |
ST14_HUMAN Suppressor of tumorigenicity 14 protein | |
8g1w[1] | B | Cyclic peptide inhibitor (ACE)Y(DTR)(NLE)(THZ)[5 a.. | A | 33.3 /39.8 |
3 /7 |
ST14_HUMAN Suppressor of tumorigenicity 14 protein | |
8g1w[1] | C | Cyclic peptide inhibitor (ACE)Y(DTR)(NLE)(KCM)[5 a.. | A | 75.0 /39.8 |
20 /21 |
ST14_HUMAN Suppressor of tumorigenicity 14 protein | |
3bn9[1] | C | E2 Fab Heavy Chain[211 aa] | A | 50.0 /39.6 |
18 /24 |
ST14_HUMAN Membrane-type serine protease 1 | |
3bn9[1] | F | E2 Fab Heavy Chain[224 aa] | D | 47.1 /39.6 |
17 /22 |
ST14_HUMAN Membrane-type serine protease 1 | |
3nps[1] | B | S4 FAB HEAVY CHAIN[226 aa] | A | 68.8 /39.6 |
16 /20 |
ST14_HUMAN Suppressor of tumorigenicity 14 protein | |
3nps[1] | C | S4 FAB LIGHT CHAIN[211 aa] | A | 60.0 /39.6 |
5 /7 |
ST14_HUMAN Suppressor of tumorigenicity 14 protein | |
6aod[1] | B | FXIa Antibody FAB Heavy Chain[211 aa] | C | 33.3 /39.6 |
6 /7 |
FA11_HUMAN Coagulation factor XI | |
7wqw[3] | A | ENTK_HUMAN Enteropeptidase non-catalytic heavy chain[261 aa] | B | 35.0 /39.0 |
20 /21 |
ENTK_HUMAN Enteropeptidase catalytic light chain | |
8h3u[1] | A | ENTK_HUMAN Enteropeptidase non-catalytic heavy chain[583 aa] | B | 40.0 /39.0 |
20 /21 |
ENTK_HUMAN Enteropeptidase catalytic light chain | |
2f9n[8] | E | Leupeptin[4 aa] | A | 92.3 /39.1 |
13 /13 |
TRYA1_HUMAN alpha I tryptase | |
2f9n[8] | H | Leupeptin[4 aa] | A | 0.0 /39.1 |
1 /1 |
TRYA1_HUMAN alpha I tryptase | |
1ekb[1] | A | ENTK_BOVIN ENTEROPEPTIDASE[7 aa] | B | 38.5 /37.7 |
13 /13 |
ENTK_BOVIN ENTEROPEPTIDASE | |
1ekb[1] | C | VAL-ASP-ASP-ASP-ASP-LYK PEPTIDE[5 aa] | B | 66.7 /37.7 |
12 /13 |
ENTK_BOVIN ENTEROPEPTIDASE | |
1z8g[1] | B | ACE-LYS-GLN-LEU-ARG-Chloromethylketone[6 aa] | A | 70.0 /37.2 |
20 /21 |
HEPS_HUMAN Serine protease hepsin | |
3t2n[2] | C | Antibody, Fab fragment, Heavy Chain[203 aa] | A | 27.3 /35.4 |
11 /12 |
HEPS_HUMAN Serine protease hepsin | |
3t2n[2] | E | Antibody, Fab fragment, Light Chain[211 aa] | A | 25.0 /35.4 |
12 /12 |
HEPS_HUMAN Serine protease hepsin | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
COMPOUND | |||||||
437 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
5f8t[4] | G |
MRZ
piperidine-1-carboximidamide[9 atoms] |
A | 80.0 /42.8 |
10 /10 |
KLKB1_HUMAN Plasma kallikrein light chain | |
5gvt[1] | C |
BMA
beta-D-mannopyranose[11 atoms] |
A | 0.0 /45.9 |
1 /1 |
KLKB1_MOUSE Plasma kallikrein | |
5gvt[1] | D |
BMA
beta-D-mannopyranose[11 atoms] |
A | 0.0 /45.9 |
1 /1 |
KLKB1_MOUSE Plasma kallikrein | |
5gvt[2] | E |
MAN
alpha-D-mannopyranose[11 atoms] |
B | 50.0 /46.2 |
2 /2 |
KLKB1_MOUSE Plasma kallikrein | |
5gvt[2] | F |
MAN
alpha-D-mannopyranose[11 atoms] |
B | 0.0 /46.2 |
1 /1 |
KLKB1_MOUSE Plasma kallikrein | |
4q2k[4] | E |
5BF
(11S)-4,9-dioxo-N-[(2S)-1-oxo-3-phenylpropan-2-yl].. |
A | 62.5 /46.1 |
16 /16 |
CTRA_BOVIN Chymotrypsinogen A | |
4q2k[2] | H |
5BF
(11S)-4,9-dioxo-N-[(2S)-1-oxo-3-phenylpropan-2-yl].. |
A | 33.3 /46.1 |
6 /6 |
CTRA_BOVIN Chymotrypsinogen A | |
1k2i[2] | C |
SN1
2,4-DIHYDROXY-TRANS CINNAMIC ACID[12 atoms] |
A | 63.6 /45.5 |
11 /11 |
CTRA_BOVIN CHYMOTRYPSINOGEN A | |
1gcd[2] | E |
DEP
DIETHYL PHOSPHONATE[8 atoms] |
A | 77.8 /45.3 |
9 /9 |
CTRA_BOVIN GAMMA-CHYMOTRYPSIN | |
1fiw[3] | D |
PBZ
P-AMINO BENZAMIDINE[10 atoms] |
A | 91.7 /46.9 |
12 /12 |
ACRO_SHEEP BETA-ACROSIN HEAVY CHAIN | |
1fiw[1] | E |
PBZ
P-AMINO BENZAMIDINE[10 atoms] |
A | 33.3 /46.9 |
6 /6 |
ACRO_SHEEP BETA-ACROSIN HEAVY CHAIN | |
5tjx[1] | B |
GBT
(8E)-3-amino-1-methyl-15-[(1H-pyrazol-1-yl)methyl].. |
A | 57.9 /44.2 |
19 /20 |
KLKB1_HUMAN Plasma kallikrein | |
7n7x[1] | B |
0RI
Orladeyo[41 atoms] |
A | 63.2 /44.2 |
19 /20 |
KLKB1_HUMAN Plasma kallikrein light chain | |
3dfl[1] | B |
GBS
4-carbamimidamidobenzoic acid[12 atoms] |
A | 76.9 /43.1 |
13 /14 |
PRSS8_HUMAN Prostasin | |
6zov[12] | E |
GBS
4-carbamimidamidobenzoic acid[12 atoms] |
A | 69.2 /39.5 |
13 /13 |
ENTK_HUMAN Enteropeptidase | |
7meq[1] | C |
GBS
4-carbamimidamidobenzoic acid[12 atoms] |
A | 78.6 /42.0 |
14 /14 |
TMPS2_HUMAN Transmembrane protease serine 2 | |
7y0f[2] | G |
I9V
2-[(1-carbamimidamido-4-chloranyl-isoquinolin-7-yl.. |
B | 66.7 /44.2 |
18 /18 |
TMPS2_HUMAN Transmembrane protease serine 2 catalytic chain | |
8v1f[2] | N |
TAM
TRIS(HYDROXYETHYL)AMINOMETHANE[11 atoms] |
B | 100.0 /44.2 |
6 /6 |
TMPS2_HUMAN Transmembrane protease serine 2 | |
8v1f[1] | P |
TAM
TRIS(HYDROXYETHYL)AMINOMETHANE[11 atoms] |
B | 20.0 /44.2 |
5 /5 |
TMPS2_HUMAN Transmembrane protease serine 2 | |
8v1f[2] | O |
7R8
6-oxidanylnaphthalene-2-carboximidamide[14 atoms] |
B | 90.0 /44.2 |
10 /10 |
TMPS2_HUMAN Transmembrane protease serine 2 | |
1zhm[3] | C |
GSH
GLUTATHIONE[14 atoms] |
A | 100.0 /42.4 |
6 /7 |
FA11_HUMAN coagulation factor XI | |
3p8f[8] | C |
GSH
GLUTATHIONE[20 atoms] |
A | 83.3 /40.1 |
6 /6 |
Q8WVC1_HUMAN ST14 protein | |
6o1g[1] | D |
7SD
N-[(6-amino-2,4-dimethylpyridin-3-yl)methyl]-1-({4.. |
A | 68.8 /43.1 |
16 /17 |
KLKB1_HUMAN Plasma kallikrein | |
6o1s[1] | D |
7SD
N-[(6-amino-2,4-dimethylpyridin-3-yl)methyl]-1-({4.. |
A | 57.9 /43.2 |
19 /20 |
KLKB1_HUMAN Plasma kallikrein | |
6t7p[1] | O |
MU8
(2~{S},4~{R})-1-[[(3~{S})-3-azanyl-2,3-dihydro-1-b.. |
A | 68.4 /43.2 |
19 /19 |
KLKB1_HUMAN Plasma kallikrein | |
1o2s[1] | D |
CR4
2-{5-[AMINO(IMINIO)METHYL]-1H-BENZIMIDAZOL-2-YL}BE.. |
A | 92.3 /40.7 |
13 /13 |
TRY1_BOVIN BETA-TRYPSIN | |
1p57[1] | C |
CR4
2-{5-[AMINO(IMINIO)METHYL]-1H-BENZIMIDAZOL-2-YL}BE.. |
B | 91.7 /42.9 |
12 /12 |
HEPS_HUMAN Serine protease hepsin | |
1o5e[1] | C |
132
6-CHLORO-2-(2-HYDROXY-BIPHENYL-3-YL)-1H-INDOLE-5-C.. |
B | 88.2 /42.9 |
17 /17 |
HEPS_HUMAN Serine protease hepsin | |
1o5f[1] | C |
CR9
2-{5-[AMINO(IMINIO)METHYL]-6-FLUORO-1H-BENZIMIDAZO.. |
B | 81.2 /42.9 |
16 /16 |
HEPS_HUMAN Serine protease hepsin | |
3e0p[1] | B |
B3C
benzyl [(1R)-1-({(2S,4R)-2-({(1S)-5-amino-1-[(S)-1.. |
A | 81.2 /42.7 |
16 /20 |
PRSS8_HUMAN Prostasin | |
3e16[1] | C |
B4C
benzyl [(1S)-5-amino-1-{[(1S)-1-({(1S)-5-amino-1-[.. |
A | 78.6 /42.7 |
14 /18 |
PRSS8_HUMAN Prostasin | |
3fvf[1] | C |
1JZ
1-[4-(hydroxymethyl)phenyl]guanidine[12 atoms] |
A | 78.6 /42.7 |
14 /14 |
PRSS8_HUMAN Prostasin | |
4crg[3] | F |
J4X
6-carbamimidoyl-N-phenyl-4-(pyrimidin-2-ylamino)na.. |
A | 62.5 /42.5 |
16 /16 |
FA11_HUMAN COAGULATION FACTOR XI | |
8bo4[1] | C |
QVI
4-(aminomethyl)-~{N}-[(2~{S})-1-oxidanylidene-3-ph.. |
A | 63.2 /42.5 |
19 /19 |
FA11_HUMAN Coagulation factor XIa light chain | |
4crc[1] | B |
OTM
(2S)-2-[[(E)-3-[5-chloranyl-2-(1,2,3,4-tetrazol-1-.. |
A | 72.7 /42.4 |
22 /22 |
FA11_HUMAN COAGULATION FACTOR XI | |
4cre[3] | B |
MVN
6-chloro-4-methyl-1H-quinolin-2-one[13 atoms] |
A | 73.3 /42.4 |
15 /15 |
FA11_HUMAN COAGULATION FACTOR XI | |
1zlr[1] | E |
368
(1R)-2-{[AMINO(IMINO)METHYL]AMINO}-1-{4-[(4R)-4-(H.. |
A | 75.0 /41.9 |
16 /16 |
FA11_HUMAN Coagulation factor XI | |
1zmj[1] | D |
HDB
(R)-1-(4-(4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-Y.. |
A | 80.0 /41.9 |
15 /15 |
FA11_HUMAN Coagulation factor XI | |
1zml[1] | I |
412
(R)-1-(4-(4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-Y.. |
A | 80.0 /41.9 |
15 /15 |
FA11_HUMAN Coagulation factor XI | |
1zmn[1] | E |
427
(R)-1-(4-(4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-Y.. |
A | 78.6 /41.9 |
14 /14 |
FA11_HUMAN Coagulation factor XI | |
1zom[1] | C |
339
(S)-2-(3-((R)-1-(4-BROMOPHENYL)ETHYL)UREIDO)-N-((S.. |
A | 70.6 /41.9 |
17 /18 |
FA11_HUMAN Coagulation factor XI | |
1zpb[1] | C |
995
4-METHYL-PENTANOIC ACID {1-[4-GUANIDINO-1-(THIAZOL.. |
A | 66.7 /41.9 |
18 /18 |
FA11_HUMAN Coagulation factor XI | |
1zpc[1] | E |
716
2-[2-(3-CHLORO-PHENYL)-2-HYDROXY-ACETYLAMINO]-N-[4.. |
A | 70.6 /41.9 |
17 /18 |
FA11_HUMAN Coagulation factor XI | |
1zsj[1] | D |
709
N-(7-CARBAMIMIDOYL-NAPHTHALEN-1-YL)-3-HYDROXY-2-ME.. |
A | 61.5 /41.9 |
13 /13 |
FA11_HUMAN Coagulation factor XI | |
1zsk[1] | E |
421
6-CARBAMIMIDOYL-4-(3-HYDROXY-2-METHYL-BENZOYLAMINO.. |
A | 66.7 /41.9 |
15 /15 |
FA11_HUMAN Coagulation factor XI | |
1ztj[1] | E |
632
2-(5-BENZYLAMINO-2-METHYLSULFANYL-6-OXO-6H-PYRIMID.. |
A | 75.0 /41.9 |
16 /17 |
FA11_HUMAN Coagulation factor XI | |
1ztk[1] | D |
62A
2-(5-AMINO-6-OXO-2-M-TOLYL-6H-PYRIMIDIN-1-YL)-N-[4.. |
A | 80.0 /41.9 |
15 /15 |
FA11_HUMAN Coagulation factor XI | |
1ztl[1] | D |
737
N-[4-GUANIDINO-1-(THIAZOLE-2-CARBONYL)-BUTYL]-2-{6.. |
A | 85.7 /41.9 |
14 /14 |
FA11_HUMAN Coagulation factor XI | |
2fda[1] | E |
682
N~2~-(AMINOCARBONYL)-N~1~-{4-{[AMINO(IMINO)METHYL].. |
A | 78.6 /41.9 |
14 /14 |
FA11_HUMAN Coagulation factor XI | |
3bg8[3] | B |
G0R
N-(4-carbamimidamidobutyl)ethanamide[11 atoms] |
A | 85.7 /41.9 |
14 /14 |
FA11_HUMAN Coagulation factor XIa light chain | |
4cr5[2] | B |
0TU
6-chloroquinolin-2(1H)-one[12 atoms] |
A | 78.6 /41.9 |
14 /14 |
FA11_HUMAN COAGULATION FACTOR XIA | |
4cr9[2] | B |
OTW
4-methylquinoline-2,6-diamine[13 atoms] |
A | 66.7 /41.9 |
12 /12 |
FA11_HUMAN COAGULATION FACTOR XI | |
4cra[3] | D |
XJ8
N-[(1S)-2-[(2-amino-5-quinolyl)methylamino]-1-benz.. |
A | 66.7 /41.9 |
18 /18 |
FA11_HUMAN COAGULATION FACTOR XI | |
4crb[2] | D |
7P0
N-[(1S)-1-benzyl-2-[2-[5-chloro-2-(tetrazol-1-yl)p.. |
A | 66.7 /41.9 |
24 /24 |
FA11_HUMAN COAGULATION FACTOR XI | |
4crd[3] | B |
OTJ
Methyl N-[4-[5-chloro-2-[[3-[5-chloro-2-(tetrazol-.. |
A | 68.2 /41.9 |
22 /22 |
FA11_HUMAN COAGULATION FACTOR XI | |
4crf[1] | E |
R9B
N-[(1S)-1-benzyl-2-[(6-chloro-2-oxo-1H-quinolin-4-.. |
A | 69.6 /41.9 |
23 /23 |
FA11_HUMAN Coagulation factor XIa light chain | |
4d76[1] | E |
J1J
N-[(2S)-1-({5-[(diaminomethylidene)amino]pentyl}am.. |
A | 68.2 /41.9 |
22 /22 |
FA11_HUMAN COAGULATION FACTOR XI | |
4d7f[1] | C |
IXA
N-[(2S)-1-({4-[(diaminomethylidene)amino]butyl}ami.. |
A | 68.2 /41.9 |
22 /22 |
FA11_HUMAN COAGULATION FACTOR XI | |
4d7g[1] | H |
E6U
N-[(1S)-1-benzyl-2-(3-guanidinopropylamino)-2-oxo-.. |
A | 65.0 /41.9 |
20 /20 |
FA11_HUMAN COAGULATION FACTOR XIA | |
4na7[1] | B |
1T5
3'-[(2S,4R)-6-carbamimidoyl-4-methyl-4-phenyl-1,2,.. |
A | 77.8 /41.9 |
18 /19 |
FA11_HUMAN Coagulation factor XI | |
4na8[1] | B |
1T6
5-aminocarbonyl-2-[3-[(2S,4R)-6-carbamimidoyl-4-me.. |
A | 68.4 /41.9 |
19 /19 |
FA11_HUMAN Coagulation factor XI | |
4ty6[1] | C |
39D
4-{2-[(1S)-1-({[trans-4-(aminomethyl)cyclohexyl]ca.. |
A | 63.2 /41.9 |
19 /19 |
FA11_HUMAN Coagulation factor XI | |
4ty7[1] | B |
39F
trans-N-{(1S)-1-[4-(3-amino-2H-indazol-6-yl)-5-chl.. |
A | 65.0 /41.9 |
20 /20 |
FA11_HUMAN Coagulation factor XI | |
4wxi[1] | B |
3VM
trans-N-{(1S)-1-[4-(3-amino-2H-indazol-6-yl)pyridi.. |
A | 65.0 /41.9 |
20 /20 |
FA11_HUMAN COAGULATION FACTOR XI, LIGHT CHAIN | |
4x6m[1] | B |
3Y3
1-{(1S)-1-[4-(3-amino-1H-indazol-6-yl)-5-chloro-1H.. |
A | 70.8 /41.9 |
24 /24 |
FA11_HUMAN Coagulation factor XI, light chain | |
4x6n[1] | C |
3Y5
1-{(1S)-1-[4-(3-amino-1H-indazol-6-yl)-5-chloro-1H.. |
A | 68.0 /41.9 |
25 /25 |
FA11_HUMAN Coagulation factor XI, light chain | |
4x6o[1] | B |
3Y4
methyl (4-{4-chloro-2-[(1S)-1-({3-[5-chloro-2-(1H-.. |
A | 68.0 /41.9 |
25 /25 |
FA11_HUMAN Coagulation factor XI, light chain | |
4y8x[1] | B |
4GR
methyl (4-{4-chloro-2-[(1S)-1-({(2E)-3-[5-chloro-2.. |
A | 68.0 /41.9 |
25 /25 |
FA11_HUMAN Coagulation factor XIa | |
4y8y[1] | B |
4D5
methyl (4-{4-chloro-2-[(1S)-1-({(2E)-3-[5-chloro-2.. |
A | 65.2 /41.9 |
23 /24 |
FA11_HUMAN Coagulation factor XIa | |
4y8z[1] | B |
4CE
(2E)-N-[(1S)-1-[5-chloro-4-(4-hydroxy-2-oxo-1,2-di.. |
A | 69.6 /41.9 |
23 /24 |
FA11_HUMAN Coagulation factor XIa | |
5e2o[1] | B |
5JM
4-[(N-{(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl.. |
A | 69.6 /41.9 |
23 /23 |
FA11_HUMAN Coagulation factor XIa light chain | |
5exl[1] | B |
5SS
4-(aminomethyl)-~{N}-[(1~{S})-1-[4-(3-oxidanyl-1~{.. |
A | 65.0 /41.9 |
20 /20 |
FA11_HUMAN Coagulation factor XIa light chain | |
5exm[1] | B |
5ST
methyl ~{N}-[4-[2-[(1~{S})-1-[[4-(aminomethyl)cycl.. |
A | 65.0 /41.9 |
20 /20 |
FA11_HUMAN Coagulation factor XIa light chain | |
5q0d[1] | B |
9EY
methyl [(7S)-7-({(2E)-3-[5-chloro-2-(1H-tetrazol-1.. |
A | 68.2 /41.9 |
22 /22 |
FA11_HUMAN Coagulation factor XI | |
5q0e[1] | B |
9FD
methyl [(4S,8S)-8-({(2E)-3-[5-chloro-2-(1H-tetrazo.. |
A | 66.7 /41.9 |
24 /24 |
FA11_HUMAN Coagulation factor XI | |
5q0f[1] | C |
9FA
methyl [(4R,5E,8S)-8-({(2E)-3-[5-chloro-2-(1H-tetr.. |
A | 66.7 /41.9 |
24 /24 |
FA11_HUMAN Coagulation factor XI | |
5q0g[1] | B |
9F7
methyl [(3R,7S)-7-({(2E)-3-[5-chloro-2-(1H-tetrazo.. |
A | 66.7 /41.9 |
24 /24 |
FA11_HUMAN Coagulation factor XI | |
5q0h[1] | B |
9F1
methyl [(4R,5E,8S)-11-chloro-8-[(2,6-difluoro-4-me.. |
A | 68.4 /41.9 |
19 /19 |
FA11_HUMAN Coagulation factor XI | |
5qck[1] | B |
BUV
4-[[(2~{S},3~{R})-1-[(~{E})-3-[5-chloranyl-2-(1,2,.. |
A | 68.0 /41.9 |
25 /25 |
FA11_HUMAN Coagulation factor XI | |
5qcl[1] | B |
BUY
4-[[(1~{S})-2-[(~{E})-3-[5-chloranyl-2-(1,2,3,4-te.. |
A | 68.0 /41.9 |
25 /25 |
FA11_HUMAN Coagulation factor XI | |
5qcm[1] | B |
BVJ
methyl ~{N}-[4-[[(1~{S})-2-[(~{E})-3-[3-chloranyl-.. |
A | 66.7 /41.9 |
24 /24 |
FA11_HUMAN Coagulation factor XI | |
5qcn[1] | B |
BVM
4-[[(1~{S})-2-[(~{E})-3-[5-chloranyl-2-(1,2,3,4-te.. |
A | 65.2 /41.9 |
23 /23 |
FA11_HUMAN Coagulation factor XI | |
5qqo[1] | C |
NRJ
methyl [(5E,8S)-8-[(6R)-6-(3-chlorophenyl)-2-oxo-1.. |
A | 65.0 /41.9 |
20 /20 |
FA11_HUMAN Coagulation factor XI | |
5qqp[1] | B |
NR7
methyl [(5E,8S)-8-[(4S)-4-(3-chlorophenyl)-2-oxopi.. |
A | 70.0 /41.9 |
20 /20 |
FA11_HUMAN Coagulation factor XI | |
5qtt[1] | B |
QEY
methyl [(3R,7S)-7-{[5-amino-1-(3-chloro-2-fluoroph.. |
A | 68.2 /41.9 |
22 /22 |
FA11_HUMAN Coagulation factor XI | |
5qtu[1] | C |
QEV
methyl [(3R,7S)-7-{[1-(3-chloro-2-fluorophenyl)-5-.. |
A | 69.6 /41.9 |
23 /23 |
FA11_HUMAN Coagulation factor XI | |
5qtv[1] | B |
QLS
methyl [(2R,7S)-7-({(2E)-3-[5-chloro-2-(1H-tetrazo.. |
A | 68.2 /41.9 |
22 /22 |
FA11_HUMAN Coagulation factor XI | |
5qtw[1] | B |
QLM
methyl (2R,7S)-7-({(2E)-3-[5-chloro-2-(1H-tetrazol.. |
A | 65.2 /41.9 |
23 /23 |
FA11_HUMAN Coagulation factor XI | |
5qtx[1] | C |
QLD
ethyl (2R,7S)-7-({(2E)-3-[5-chloro-2-(1H-tetrazol-.. |
A | 62.5 /41.9 |
24 /24 |
FA11_HUMAN Coagulation factor XI | |
5qty[1] | B |
QLJ
ethyl (2R,7S)-7-({(2E)-3-[5-chloro-2-(1H-tetrazol-.. |
A | 62.5 /41.9 |
24 /24 |
FA11_HUMAN Coagulation factor XI | |
5tks[1] | B |
7DL
((15S)-18-CHLORO- 15-(((2E)-3-(5-CHLORO-2-(1H-TETR.. |
A | 68.2 /41.9 |
22 /22 |
FA11_HUMAN Coagulation factor XI | |
5tkt[1] | B |
7DS
METHYL ((12E,15S)-15-(((2E)-3-(5-CHLORO-2-(1H-TETR.. |
A | 65.2 /41.9 |
23 /23 |
FA11_HUMAN Factor XIa (Light Chain) | |
5tku[1] | B |
7DK
METHYL ((15S)-15-(((2E)-3-(5-CHLORO-2-(1H-TETRAZOL.. |
A | 68.2 /41.9 |
22 /22 |
FA11_HUMAN Factor XIa (Light Chain) | |
5wb6[1] | B |
9ZM
methyl [(11S)-11-({(2E)-3-[5-chloro-2-(1H-tetrazol.. |
A | 68.0 /41.9 |
25 /26 |
FA11_HUMAN Coagulation factor XI | |
6c0s[1] | B |
EEJ
methyl (4-{6-[(1S)-2-[(3R)-1-acetylpiperidin-3-yl].. |
A | 68.0 /41.9 |
25 /25 |
FA11_HUMAN Coagulation factor XI | |
6w50[1] | B |
SWP
methyl ((10R,14S)-14-(4-(3-chloro-2,6-difluorophen.. |
A | 70.8 /41.9 |
24 /24 |
FA11_HUMAN Coagulation factor XI | |
1zpz[1] | C |
BUK
N~2~-({[(1R)-1-(4-BROMOPHENYL)ETHYL]AMINO}CARBONYL.. |
A | 66.7 /41.8 |
18 /19 |
FA11_HUMAN Coagulation factor XI | |
3sor[1] | C |
O58
{4-[(N-{3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]pro.. |
A | 63.6 /41.5 |
22 /22 |
FA11_HUMAN Coagulation factor XI | |
3sos[1] | D |
O61
N-[(2S)-1-({2-[5-chloro-2-(1H-tetrazol-1-yl)phenyl.. |
A | 68.2 /41.5 |
22 /22 |
FA11_HUMAN Coagulation factor XI | |
4x6p[2] | D |
3YU
(2E)-N-{(1S)-1-[4-(3-amino-1H-indazol-6-yl)-1H-imi.. |
A | 69.6 /41.5 |
23 /23 |
FA11_HUMAN Coagulation factor XI, light chain | |
5exn[1] | C |
5SU
methyl ~{N}-[4-[2-[(1~{S})-1-[[(~{E})-3-[5-chloran.. |
A | 66.7 /41.5 |
24 /24 |
FA11_HUMAN Coagulation factor XIa light chain | |
6ts5[1] | B |
NW2
2-[2-[3-[(3~{S})-3-azanyl-2,3-dihydro-1-benzofuran.. |
A | 70.6 /41.5 |
17 /18 |
FA11_HUMAN Coagulation factor XI | |
6ts6[1] | H |
NW5
2-[2-[[3-[(3~{S})-3-azanyl-2,3-dihydro-1-benzofura.. |
A | 70.6 /41.5 |
17 /17 |
FA11_HUMAN Coagulation factor XI | |
6ts7[1] | B |
NWE
2-[2-[[3-(1,2,3,4-tetrahydroisoquinolin-7-yl)pheny.. |
A | 80.0 /41.5 |
15 /15 |
FA11_HUMAN Coagulation factor XI | |
6usy[1] | B |
QGS
1-[(2S)-2-{3-[(3S)-3-amino-2,3-dihydro-1-benzofura.. |
A | 70.6 /41.5 |
17 /17 |
FA11_HUMAN Coagulation factor XIa light chain | |
6vlu[1] | C |
R2Y
N-cyclohexyl-D-leucyl-N-[(1-aminoisoquinolin-6-yl).. |
A | 64.7 /41.5 |
17 /18 |
FA11_HUMAN Coagulation factor XIa light chain | |
6vlv[1] | D |
R3A
1-carbamimidamido-4-chloro-N-[(2R)-3-methyl-1-(mor.. |
A | 58.8 /41.5 |
17 /17 |
FA11_HUMAN Coagulation factor XIa light chain | |
7mbo[1] | C |
YXG
Milvexian[43 atoms] |
A | 66.7 /41.5 |
24 /24 |
FA11_HUMAN Coagulation factor XIa light chain | |
7v0z[1] | B |
OQ6
methyl ~{N}-[4-[1-[(1~{R})-1-[5-[5-chloranyl-2-(1,.. |
A | 69.6 /41.5 |
23 /23 |
FA11_HUMAN Coagulation factor XIa light chain | |
7v10[1] | B |
OQI
methyl ~{N}-[4-[1-[(1~{R})-1-[5-[3-chloranyl-2-flu.. |
A | 68.2 /41.5 |
22 /22 |
FA11_HUMAN Coagulation factor XIa light chain | |
7v11[1] | B |
OQO
5-[1-[(1~{R})-1-[5-[3-chloranyl-2-fluoranyl-6-(1,2.. |
A | 66.7 /41.5 |
24 /24 |
FA11_HUMAN Coagulation factor XIa light chain | |
7v12[1] | B |
OR0
5-[1-[(1~{R})-1-[5-[3-chloranyl-2-fluoranyl-6-(1,2.. |
A | 68.2 /41.5 |
22 /22 |
FA11_HUMAN Coagulation factor XIa light chain | |
7v13[1] | C |
ORF
3-chloranyl-4-[1-[(1~{R})-1-[5-[3-chloranyl-2-fluo.. |
A | 72.7 /41.5 |
22 /22 |
FA11_HUMAN Coagulation factor XIa light chain | |
7v14[1] | C |
ORU
5-[1-[(1~{R})-1-[5-[3-chloranyl-2-fluoranyl-6-(1,2.. |
A | 68.2 /41.5 |
22 /22 |
FA11_HUMAN Coagulation factor XIa light chain | |
7v15[1] | C |
OSX
5-[1-[(1~{R})-1-[5-[3-chloranyl-2-fluoranyl-6-(1,2.. |
A | 66.7 /41.5 |
24 /24 |
FA11_HUMAN Coagulation factor XIa light chain | |
7v16[1] | C |
OT7
5-[3-chloranyl-2-fluoranyl-6-(1,2,3,4-tetrazol-1-y.. |
A | 66.7 /41.5 |
24 /24 |
FA11_HUMAN Coagulation factor XIa light chain | |
7v17[1] | C |
OTL
5-[3-chloranyl-2-fluoranyl-6-(1,2,3,4-tetrazol-1-y.. |
A | 72.7 /41.5 |
22 /22 |
FA11_HUMAN Coagulation factor XIa light chain | |
7v18[1] | C |
OTX
2-[(1~{R})-3-[bis(fluoranyl)methoxy]-1-[4-(3-methy.. |
A | 70.8 /41.5 |
24 /24 |
FA11_HUMAN Coagulation factor XIa light chain | |
8bo3[1] | B |
QV3
4-[[(2~{S})-2-[4-[5-chloranyl-2-[4-(trifluoromethy.. |
A | 62.5 /41.5 |
24 /24 |
FA11_HUMAN Coagulation factor XIa light chain | |
8bo5[1] | B |
QVO
2-[4-(3-chlorophenyl)-2,5-bis(oxidanylidene)pyrrol.. |
A | 65.0 /41.5 |
20 /20 |
FA11_HUMAN Coagulation factor XIa light chain | |
8bo6[1] | B |
QW0
(~{E})-~{N}-[[5-(3-azanyl-1~{H}-indazol-6-yl)-4-ch.. |
A | 63.6 /41.5 |
22 /22 |
FA11_HUMAN Coagulation factor XIa light chain | |
8bo7[1] | B |
QW6
4-[[(2~{S})-2-[4-(5-chloranyl-2-cyano-phenyl)-3-me.. |
A | 66.7 /41.5 |
21 /21 |
FA11_HUMAN Coagulation factor XIa light chain | |
4doq[1] | F |
XPE
3,6,9,12,15,18,21,24,27-NONAOXANONACOSANE-1,29-DIO.. |
A | 28.6 /41.4 |
7 /7 |
TRYP_PIG Trypsin | |
8f7v[2] | C |
EUA
(6S,9R,19S,22R)-N-{[4-(aminomethyl)phenyl]methyl}-.. |
A | 68.8 /40.3 |
16 /16 |
PLMN_HUMAN Plasminogen | |
1xx9[4] | E |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 0.0 /41.9 |
2 /2 |
FA11_HUMAN Coagulation factor XI | |
2f9n[2] | L |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
B | 33.3 /39.1 |
3 /3 |
TRYA1_HUMAN alpha I tryptase | |
4x6p[2] | C |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 25.0 /41.5 |
4 /4 |
FA11_HUMAN Coagulation factor XI, light chain | |
5eod[4] | E |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 50.0 /42.4 |
2 /3 |
FA11_HUMAN Coagulation factor XI | |
5eok[1] | F |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 0.0 /42.4 |
1 /1 |
FA11_HUMAN Coagulation factor XI | |
6o1g[1] | B |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 0.0 /43.1 |
1 /1 |
KLKB1_HUMAN Plasma kallikrein | |
7wqw[3] | H |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
B | 0.0 /39.0 |
2 /2 |
ENTK_HUMAN Enteropeptidase catalytic light chain | |
7wqw[3] | I |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
B | 0.0 /39.0 |
2 /2 |
ENTK_HUMAN Enteropeptidase catalytic light chain | |
7wqw[3] | J |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
B | 0.0 /39.0 |
1 /1 |
ENTK_HUMAN Enteropeptidase catalytic light chain | |
7wqw[3] | K |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
B | 0.0 /39.0 |
3 /3 |
ENTK_HUMAN Enteropeptidase catalytic light chain | |
7wqx[1] | B |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 0.0 /38.3 |
4 /4 |
ENTK_HUMAN Enteropeptidase | |
7wqx[1] | E |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 0.0 /38.3 |
2 /2 |
ENTK_HUMAN Enteropeptidase | |
7wqx[1] | F |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 25.0 /38.3 |
4 /4 |
ENTK_HUMAN Enteropeptidase | |
7wqx[1] | G |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 0.0 /38.3 |
2 /2 |
ENTK_HUMAN Enteropeptidase | |
7wqx[1] | H |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 0.0 /38.3 |
1 /1 |
ENTK_HUMAN Enteropeptidase | |
8a3q[1] | D |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 50.0 /42.8 |
2 /2 |
KLKB1_HUMAN Plasma kallikrein | |
8fgx[1] | D |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
C | 33.3 /43.1 |
3 /3 |
KLKB1_HUMAN Plasma kallikrein light chain | |
8fgx[1] | E |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
C | 100.0 /43.1 |
3 /4 |
KLKB1_HUMAN Plasma kallikrein light chain | |
8fgx[1] | F |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
C | 0.0 /43.1 |
1 /1 |
KLKB1_HUMAN Plasma kallikrein light chain | |
8s0l[2] | C |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 0.0 /42.6 |
2 /3 |
TMPS2_HUMAN Transmembrane protease serine 2 | |
1ntp[1] | B |
ISP
PHOSPHORYLISOPROPANE[7 atoms] |
A | 100.0 /41.1 |
7 /7 |
TRY1_BOVIN BETA-TRYPSIN | |
1bru[1] | B |
1NB
2-(2-HYDROXY-CYCLOPENTYL)-PENT-4-ENAL[12 atoms] |
A | 80.0 /41.1 |
10 /10 |
ELA2_PIG ELASTASE | |
1s5s[3] | C |
PG3
GUANIDINE-3-PROPANOL[8 atoms] |
A | 91.7 /41.0 |
12 /12 |
TRYP_PIG Trypsin | |
1s6f[1] | E |
SBP
[3-(1,3,2-DIOXABOROLAN-2-YLOXY)PROPYL]GUANIDINE[13.. |
A | 87.5 /41.0 |
16 /16 |
TRYP_PIG Trypsin | |
1s6h[1] | F |
4BZ
4-(HYDROXYMETHYL)BENZAMIDINE[11 atoms] |
A | 91.7 /41.0 |
12 /12 |
TRYP_PIG Trypsin | |
1s84[1] | L |
DYB
4-(1,3,2-DIOXABOROLAN-2-YLOXY)BUTAN-1-AMINIUM[11 a.. |
A | 85.7 /41.0 |
14 /14 |
TRYP_PIG TRYPSIN | |
1s85[1] | D |
SBZ
[4-(1,3,2-DIOXABOROLAN-2-YLOXY)METHYL]BENZAMIDINE[.. |
A | 86.7 /41.0 |
15 /15 |
TRYP_PIG TRYPSIN | |
2a32[1] | E |
PBC
PHENYL BORONIC ACID[8 atoms] |
A | 100.0 /41.0 |
4 /4 |
TRYP_PIG Trypsin | |
2a32[1] | I |
CXS
3-CYCLOHEXYL-1-PROPYLSULFONIC ACID[14 atoms] |
A | 0.0 /41.0 |
2 /2 |
TRYP_PIG Trypsin | |
1zrk[1] | E |
367
3-HYDROXYPROPYL 3-[({7-[AMINO(IMINO)METHYL]-1-NAPH.. |
A | 61.5 /41.0 |
13 /13 |
FA11_HUMAN Coagulation factor XI | |
1zsl[1] | B |
624
2-(2-(3,4-DICHLOROPHENYL)-5-(ISOPROPYLAMINO)-6-OXO.. |
A | 70.6 /41.0 |
17 /18 |
FA11_HUMAN Coagulation factor XI | |
6ts4[1] | K |
J7B
2-[2-[[3-[3-(aminomethyl)phenyl]phenyl]carbonylami.. |
A | 68.8 /41.0 |
16 /16 |
FA11_HUMAN Coagulation factor XI | |
7ths[2] | C |
I5Y
(6S,9R,20R,23S)-N-{[4-(aminomethyl)phenyl]methyl}-.. |
A | 68.8 /39.9 |
16 /16 |
PLMN_HUMAN Plasminogen | |
1az8[1] | B |
IN4
+/-METHYL 4-(AMINOIMINOMETHYL)-BETA-[3- INH (AMINO.. |
A | 73.7 /40.7 |
19 /20 |
TRY1_BOVIN TRYPSIN | |
1max[2] | C |
ZAP
[N-(BENZYLOXYCARBONYL)AMINO](4-AMIDINOPHENYL)METHA.. |
A | 93.3 /40.7 |
15 /16 |
TRY1_BOVIN BETA-TRYPSIN | |
1o2t[1] | D |
783
3-{5-[AMINO(IMINIO)METHYL]-1H-INDOL-2-YL}-5-METHOX.. |
A | 86.7 /40.7 |
15 /15 |
TRY1_BOVIN BETA-TRYPSIN | |
1o2u[4] | C |
847
2-(3-{5-[AMINO(IMINIO)METHYL]-1H-BENZIMIDAZOL-2-YL.. |
A | 91.7 /40.7 |
12 /12 |
TRY1_BOVIN BETA-TRYPSIN | |
1o31[3] | C |
801
2-{5-[AMINO(IMINIO)METHYL]-1H-BENZIMIDAZOL-2-YL}PY.. |
A | 92.3 /40.7 |
13 /13 |
TRY1_BOVIN BETA-TRYPSIN | |
1o37[2] | C |
653
5-(2-AMINOETHYL)-3-{5-[AMINO(IMINIO)METHYL]-1H-BEN.. |
A | 92.9 /40.7 |
14 /14 |
TRY1_BOVIN BETA-TRYPSIN | |
1o39[5] | C |
780
3-{5-[AMINO(IMINIO)METHYL]-1H-BENZIMIDAZOL-2-YL}-1.. |
A | 92.9 /40.7 |
14 /14 |
TRY1_BOVIN BETA-TRYPSIN | |
1o3e[2] | D |
696
3-{5-[AMINO(IMINIO)METHYL]-1H-INDOL-2-YL}-1,1'-BIP.. |
A | 86.7 /40.7 |
15 /15 |
TRY1_BOVIN BETA-TRYPSIN | |
1o3h[2] | D |
907
2-{5-[AMINO(IMINIO)METHYL]-1H-INDOL-2-YL}-6-BROMO-.. |
A | 92.3 /40.7 |
13 /13 |
TRY1_BOVIN BETA-TRYPSIN | |
1o3j[2] | C |
334
2-{5-[AMINO(IMINIO)METHYL]-1H-BENZIMIDAZOL-2-YL}-6.. |
A | 92.3 /40.7 |
13 /13 |
TRY1_BOVIN BETA-TRYPSIN | |
1o3l[1] | D |
678
(3-{5-[AMINO(IMINIO)METHYL]-1H-INDOL-2-YL}-5-BROMO.. |
A | 92.3 /40.7 |
13 /13 |
TRY1_BOVIN BETA-TRYPSIN | |
1o3m[3] | D |
785
2-{5-[AMINO(IMINIO)METHYL]-1H-BENZIMIDAZOL-2-YL}-4.. |
A | 91.7 /40.7 |
12 /12 |
TRY1_BOVIN BETA-TRYPSIN | |
1tpp[1] | D |
APA
(2S)-3-(4-carbamimidoylphenyl)-2-hydroxypropanoic .. |
A | 93.3 /40.7 |
15 /15 |
TRY1_BOVIN BETA-TRYPSIN | |
1tx7[1] | C |
4CM
(4-CARBAMIMIDOYLPHENYL)-METHYL-PHOSPHINIC ACID[13 .. |
A | 90.9 /40.7 |
11 /11 |
TRY1_BOVIN Trypsinogen | |
1tx8[1] | C |
AM4
4-(METHYLSULFONYL)BENZENECARBOXIMIDAMIDE[13 atoms].. |
A | 90.9 /40.7 |
11 /11 |
TRY1_BOVIN Trypsinogen | |
1xuf[1] | C |
BAZ
BIS(5-AMIDINO-BENZIMIDAZOLYL)METHANE ZINC[26 atoms.. |
A | 87.5 /40.7 |
16 /16 |
TRY1_BOVIN TRYPSIN | |
1xug[1] | D |
BAB
BIS(5-AMIDINO-BENZIMIDAZOLYL)METHANE[25 atoms] |
A | 84.6 /40.7 |
13 /13 |
TRY1_BOVIN TRYPSIN | |
2fx4[1] | C |
C1R
4-PIPERIDINEBUTYRATE[11 atoms] |
A | 92.9 /40.7 |
14 /14 |
TRY1_BOVIN trypsin | |
2fx6[1] | C |
270
2H-BENZOIMIDAZOL-2-YLAMINE[10 atoms] |
A | 91.7 /40.7 |
12 /12 |
TRY1_BOVIN Trypsin | |
2zft[1] | C |
10U
(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylami.. |
A | 80.0 /40.7 |
15 /17 |
TRY1_BOVIN Cationic trypsin | |
3a7t[2] | E |
4FZ
4-formylbenzenecarboximidamide[11 atoms] |
A | 91.7 /40.7 |
12 /12 |
TRY1_BOVIN Cationic trypsin | |
3a7v[1] | E |
3FZ
3-formylbenzenecarboximidamide[11 atoms] |
A | 91.7 /40.7 |
12 /12 |
TRY1_BOVIN Cationic trypsin | |
3a7z[1] | D |
O14
(E)-4-((1-methylpiperidin-4-yloxyimino)methyl)benz.. |
A | 90.9 /40.7 |
11 /11 |
TRY1_BOVIN Cationic trypsin | |
3a81[3] | F |
H06
(E)-4-((2-nicotinoylhydrazono)methyl)benzimidamide.. |
A | 90.9 /40.7 |
11 /11 |
TRY1_BOVIN Cationic trypsin | |
3a84[4] | D |
O09
(E)-2-(4-carbamimidoylbenzylideneaminooxy)acetic a.. |
A | 92.3 /40.7 |
13 /13 |
TRY1_BOVIN Cationic trypsin | |
3a8b[1] | L |
BR6
(E)-4-((4-bromophenylimino)methyl)benzimidamide[18.. |
A | 92.3 /40.7 |
13 /13 |
TRY1_BOVIN Cationic trypsin | |
3aav[2] | C |
A2C
3,3'-[ethane-1,2-diylbis(nitrilomethylylidene)]bis.. |
A | 80.0 /40.7 |
15 /15 |
TRY1_BOVIN Cationic trypsin | |
3ljo[1] | B |
11U
(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexylamin.. |
A | 84.6 /40.7 |
13 /14 |
TRY1_BOVIN Cationic trypsin | |
4ab9[1] | G |
VXQ
1-(2,3-dihydro-1-benzofuran-5-yl)methanamine[11 at.. |
A | 91.7 /40.7 |
12 /12 |
TRY1_BOVIN CATIONIC TRYPSIN | |
4abd[1] | H |
SW2
1-[3-(1H-pyrrol-1-yl)phenyl]methanamine[13 atoms] |
A | 90.9 /40.7 |
11 /11 |
TRY1_BOVIN CATIONIC TRYPSIN | |
4abg[1] | K |
91B
1-[3-(4-METHYLPIPERAZIN-1-YL)PHENYL]METHANAMINE[15.. |
A | 90.9 /40.7 |
11 /11 |
TRY1_BOVIN CATIONIC TRYPSIN | |
1utj[1] | B |
ABN
BENZYLAMINE[8 atoms] |
A | 90.9 /40.5 |
11 /11 |
TRY1_SALSA TRYPSIN I | |
1utl[1] | B |
PRA
3-PHENYLPROPYLAMINE[10 atoms] |
A | 90.9 /40.5 |
11 /11 |
TRY1_SALSA TRYPSIN I | |
1utm[1] | B |
PEA
2-PHENYLETHYLAMINE[9 atoms] |
A | 83.3 /40.5 |
6 /6 |
TRY1_SALSA TRYPSIN I | |
1ql9[1] | D |
ZEN
[4-(6-CHLORO-NAPHTHALENE-2-SULFONYL)-PIPERAZIN-1-Y.. |
A | 73.7 /40.4 |
19 /19 |
TRY2_RAT TRYPSIN | |
1bui[1] | D |
0GJ
L-alpha-glutamyl-N-{(1S)-4-{[amino(iminio)methyl]a.. |
A | 91.7 /40.3 |
12 /12 |
PLMN_HUMAN Plasminogen | |
5ugd[1] | B |
89S
Nalpha-[trans-4-(aminomethyl)cyclohexane-1-carbony.. |
A | 76.5 /40.3 |
17 /17 |
PLMN_HUMAN Plasminogen | |
5ugg[1] | B |
89M
Nalpha-[trans-4-(aminomethyl)cyclohexane-1-carbony.. |
A | 81.2 /40.3 |
16 /16 |
PLMN_HUMAN Plasminogen | |
7uah[2] | C |
M63
(6S,9R,19S,22R)-N-{[4-(aminomethyl)phenyl]methyl}-.. |
A | 68.8 /39.9 |
16 /16 |
PLMN_HUMAN Plasminogen | |
8f7u[2] | C |
GGI
(5S,8R,18S,21R)-N-{[4-(aminomethyl)phenyl]methyl}-.. |
A | 57.9 /40.3 |
19 /19 |
PLMN_HUMAN Activation peptide | |
1a0j[19] | K |
BEN
BENZAMIDINE[9 atoms] |
B | 90.9 /40.2 |
11 /11 |
TRY3_SALSA TRYPSIN | |
1eax[11] | C |
BEN
BENZAMIDINE[9 atoms] |
A | 91.7 /40.1 |
12 /12 |
ST14_HUMAN SUPPRESSOR OF TUMORIGENICITY 14 | |
1hj8[1] | C |
BEN
BENZAMIDINE[9 atoms] |
A | 0.0 /40.5 |
2 /2 |
TRY1_SALSA TRYPSIN I | |
2oq5[1] | B |
BEN
BENZAMIDINE[9 atoms] |
A | 83.3 /39.7 |
12 /12 |
TM11E_HUMAN Transmembrane protease, serine 11E | |
6i44[1] | C |
BEN
BENZAMIDINE[9 atoms] |
A | 72.7 /43.1 |
11 /11 |
KLKB1_HUMAN Plasma kallikrein | |
2gv6[1] | B |
730
(S)-3-(3-(4-(2-GUANIDINOETHYL)PIPERIDIN-1-YL)-2-(N.. |
A | 80.0 /40.1 |
15 /16 |
ST14_HUMAN Suppressor of tumorigenicity 14 | |
2gv7[1] | B |
672
(S)-4-(4-(3-(3-CARBAMIMIDOYLPHENYL)-2-(2,4,6-TRIIS.. |
A | 76.5 /40.1 |
17 /20 |
ST14_HUMAN Suppressor of tumorigenicity 14 | |
4jyt[1] | B |
N4A
4,4'-[{3-[(naphthalen-2-ylsulfonyl)amino]pyridine-.. |
A | 82.4 /40.1 |
17 /17 |
ST14_HUMAN Suppressor of tumorigenicity 14 protein | |
4jz1[1] | B |
F4D
4,4'-[(3-{[(4-fluorophenyl)sulfonyl]amino}pyridine.. |
A | 87.5 /40.1 |
16 /19 |
ST14_HUMAN Suppressor of tumorigenicity 14 protein | |
4jzi[1] | B |
N4C
N-(trans-4-aminocyclohexyl)-2,6-bis(4-carbamimidoy.. |
A | 78.6 /40.1 |
14 /15 |
ST14_HUMAN Suppressor of tumorigenicity 14 protein | |
4o97[1] | C |
NTX
N-(trans-4-aminocyclohexyl)-3,5-bis[(3-carbamimido.. |
A | 83.3 /40.1 |
12 /16 |
ST14_HUMAN Suppressor of tumorigenicity 14 protein | |
4o9v[1] | C |
NT4
N-(trans-4-aminocyclohexyl)-3,5-bis(4-carbamimidoy.. |
A | 85.7 /40.1 |
14 /18 |
ST14_HUMAN Suppressor of tumorigenicity 14 protein | |
4r0i[1] | C |
3KM
3-({(2S)-3-[4-(2-aminoethyl)piperidin-1-yl]-2-[(na.. |
A | 78.6 /40.1 |
14 /15 |
ST14_HUMAN Suppressor of tumorigenicity 14 protein | |
6n4t[1] | E |
KD7
N-(3-phenylpropanoyl)-3-(1,3-thiazol-4-yl)-L-alany.. |
A | 77.8 /40.1 |
18 /20 |
ST14_HUMAN Suppressor of tumorigenicity 14 protein | |
6n4t[1] | F |
144
TRIS-HYDROXYMETHYL-METHYL-AMMONIUM[8 atoms] |
A | 0.0 /40.1 |
3 /3 |
ST14_HUMAN Suppressor of tumorigenicity 14 protein | |
6t9t[1] | C |
MXH
1-~{tert}-butyl-3-[1-[(2~{S})-3-(3-carbamimidoylph.. |
A | 75.0 /39.8 |
16 /20 |
ST14_HUMAN Suppressor of tumorigenicity 14 protein | |
3ncl[1] | B |
CCZ
phenyl (4-carbamimidoylbenzyl)phosphonate[20 atoms.. |
A | 87.5 /39.6 |
16 /16 |
ST14_HUMAN Suppressor of tumorigenicity 14 protein | |
8g1v[1] | M |
YIL
N~2~-{[3-(acetamidomethyl)phenyl]acetyl}-N-[(2S)-1.. |
A | 82.4 /39.6 |
17 /18 |
ST14_HUMAN Suppressor of tumorigenicity 14 protein | |
1y59[1] | D |
TL1
2,5-BIS-O-{3-[AMINO(IMINO)METHYL]PHENYL}-1,4:3,6-D.. |
A | 64.3 /39.2 |
14 /14 |
TRY1_BOVIN Trypsin, cationic | |
1y5a[1] | D |
TL2
2-O-{4-[AMINO(IMINO)METHYL]PHENYL}-5-O-{3-[AMINO(I.. |
A | 64.3 /39.2 |
14 /14 |
TRY1_BOVIN Trypsin, cationic | |
1y5b[1] | E |
TL3
2,5-BIS-O-{4-[AMINO(IMINO)METHYL]PHENYL}-1,4:3,6-D.. |
A | 85.7 /39.2 |
14 /14 |
TRY1_BOVIN Trypsin, cationic | |
1y5u[1] | E |
TL4
2-O-{3-[AMINO(IMINO)METHYL]PHENYL}-5-O-{4-[AMINO(I.. |
A | 66.7 /39.2 |
15 /15 |
TRY1_BOVIN Trypsin, cationic | |
5ce1[1] | B |
50K
2-[6-(1-hydroxycyclohexyl)pyridin-2-yl]-1H-indole-.. |
A | 76.9 /37.6 |
13 /13 |
HEPS_HUMAN Serine protease hepsin | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
METAL | |||||||
437 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
1an1[126] | C |
CA
CALCIUM ION[1 atoms] |
A | 50.0 /41.2 |
4 /5 |
TRYP_PIG TRYPSIN | |
1tgs[1] | D |
CA
CALCIUM ION[1 atoms] |
A | 0.0 /40.5 |
3 /4 |
TRY1_BOVIN TRYPSINOGEN | |
1utj[4] | C |
CA
CALCIUM ION[1 atoms] |
A | 50.0 /40.5 |
4 /5 |
TRY1_SALSA TRYPSIN I | |
3gyl[1] | B |
CA
CALCIUM ION[1 atoms] |
A | 33.3 /42.7 |
3 /3 |
PRSS8_HUMAN Prostasin | |
4an7[5] | C |
CA
CALCIUM ION[1 atoms] |
A | 66.7 /41.0 |
3 /4 |
TRYP_PIG TRYPSIN | |
4bnr[2] | E |
CA
CALCIUM ION[1 atoms] |
A | 0.0 /41.6 |
3 /5 |
Q52V24_PONLE HEPATOPANCREAS TRYPSIN | |
4bnr[2] | F |
CA
CALCIUM ION[1 atoms] |
A | 25.0 /41.6 |
4 /4 |
Q52V24_PONLE HEPATOPANCREAS TRYPSIN | |
8s0l[1] | D |
CA
CALCIUM ION[1 atoms] |
A | 60.0 /42.6 |
5 /6 |
TMPS2_HUMAN Transmembrane protease serine 2 | |
8v04[1] | J |
CA
CALCIUM ION[1 atoms] |
B | 0.0 /44.2 |
1 /1 |
TMPS2_HUMAN Transmembrane protease serine 2 | |
1s83[2] | D |
MG
MAGNESIUM ION[1 atoms] |
A | 0.0 /41.0 |
2 /2 |
TRYP_PIG TRYPSIN | |
6n4t[1] | B |
MG
MAGNESIUM ION[1 atoms] |
A | 33.3 /40.1 |
3 /3 |
ST14_HUMAN Suppressor of tumorigenicity 14 protein | |
8vis[2] | I |
MG
MAGNESIUM ION[1 atoms] |
B | 0.0 /43.7 |
1 /1 |
TM11D_HUMAN Transmembrane protease serine 11D catalytic chain | |
7meq[1] | D |
UNX
UNKNOWN ATOM OR ION[1 atoms] |
A | 0.0 /42.0 |
2 /2 |
TMPS2_HUMAN Transmembrane protease serine 2 | |
7meq[1] | E |
UNX
UNKNOWN ATOM OR ION[1 atoms] |
A | 0.0 /42.0 |
1 /1 |
TMPS2_HUMAN Transmembrane protease serine 2 | |
8v1f[2] | H |
UNX
UNKNOWN ATOM OR ION[1 atoms] |
B | 100.0 /44.2 |
1 /1 |
TMPS2_HUMAN Transmembrane protease serine 2 | |
8vis[1] | M |
UNX
UNKNOWN ATOM OR ION[1 atoms] |
D | 33.3 /43.7 |
3 /3 |
TM11D_HUMAN Transmembrane protease serine 11D catalytic chain | |
8vis[1] | P |
UNX
UNKNOWN ATOM OR ION[1 atoms] |
F | 0.0 /43.7 |
2 /2 |
TM11D_HUMAN Transmembrane protease serine 11D catalytic chain | |
8vis[1] | R |
UNX
UNKNOWN ATOM OR ION[1 atoms] |
H | 100.0 /43.7 |
2 /2 |
TM11D_HUMAN Transmembrane protease serine 11D catalytic chain | |
8vis[1] | T |
UNX
UNKNOWN ATOM OR ION[1 atoms] |
H | 0.0 /43.7 |
1 /1 |
TM11D_HUMAN Transmembrane protease serine 11D catalytic chain | |
6twb[1] | D |
NH4
AMMONIUM ION[1 atoms] |
A | 0.0 /41.9 |
1 /1 |
FA11_HUMAN Coagulation factor XI | |
6twb[1] | E |
NH4
AMMONIUM ION[1 atoms] |
A | 33.3 /41.9 |
3 /3 |
FA11_HUMAN Coagulation factor XI | |
1gl0[4] | C |
CD
CADMIUM ION[1 atoms] |
A | 100.0 /44.7 |
2 /2 |
CTRA_BOVIN CHYMOTRYPSINOGEN A | |
1gl0[1] | D |
CD
CADMIUM ION[1 atoms] |
A | 0.0 /44.7 |
1 /1 |
CTRA_BOVIN CHYMOTRYPSINOGEN A | |
1l4z[2] | C |
CD
CADMIUM ION[1 atoms] |
A | 0.0 /40.3 |
1 /1 |
PLMN_HUMAN Plasminogen | |
1l4z[2] | D |
CD
CADMIUM ION[1 atoms] |
A | 0.0 /40.3 |
3 /3 |
PLMN_HUMAN Plasminogen | |
1l4z[4] | E |
CD
CADMIUM ION[1 atoms] |
A | 50.0 /40.3 |
2 /2 |
PLMN_HUMAN Plasminogen | |
1l4z[2] | E |
CD
CADMIUM ION[1 atoms] |
A | 100.0 /40.3 |
1 /1 |
PLMN_HUMAN Plasminogen | |
1l4z[2] | F |
CD
CADMIUM ION[1 atoms] |
A | 0.0 /40.3 |
1 /1 |
PLMN_HUMAN Plasminogen | |
2f91[1] | C |
CD
CADMIUM ION[1 atoms] |
A | 0.0 /41.6 |
4 /6 |
Q52V24_PONLE hepatopancreas trypsin | |
2f91[1] | D |
CD
CADMIUM ION[1 atoms] |
A | 0.0 /41.6 |
1 /1 |
Q52V24_PONLE hepatopancreas trypsin | |
2f91[1] | E |
CD
CADMIUM ION[1 atoms] |
A | 0.0 /41.6 |
1 /1 |
Q52V24_PONLE hepatopancreas trypsin | |
2f91[1] | F |
CD
CADMIUM ION[1 atoms] |
A | 0.0 /41.6 |
1 /1 |
Q52V24_PONLE hepatopancreas trypsin | |
2f91[1] | G |
CD
CADMIUM ION[1 atoms] |
A | 25.0 /41.6 |
4 /4 |
Q52V24_PONLE hepatopancreas trypsin | |
2f91[1] | H |
CD
CADMIUM ION[1 atoms] |
A | 0.0 /41.6 |
1 /1 |
Q52V24_PONLE hepatopancreas trypsin | |
1and[2] | B |
CU
COPPER (II) ION[1 atoms] |
A | 50.0 /40.4 |
2 /2 |
TRY2_RAT ANIONIC TRYPSIN | |
3aav[2] | E |
CU
COPPER (II) ION[1 atoms] |
A | 100.0 /40.7 |
1 /1 |
TRY1_BOVIN Cationic trypsin | |
1ekb[1] | D |
ZN
ZINC ION[1 atoms] |
B | 0.0 /37.7 |
1 /1 |
ENTK_BOVIN ENTEROPEPTIDASE | |
1ekb[1] | E |
ZN
ZINC ION[1 atoms] |
B | 0.0 /37.7 |
2 /3 |
ENTK_BOVIN ENTEROPEPTIDASE | |
1xug[1] | C |
ZN
ZINC ION[1 atoms] |
A | 100.0 /40.7 |
3 /3 |
TRY1_BOVIN TRYPSIN | |
1eja[1] | C |
NA
SODIUM ION[1 atoms] |
A | 50.0 /41.0 |
4 /5 |
TRYP_PIG TRYPSIN | |
1s81[2] | C |
NA
SODIUM ION[1 atoms] |
A | 83.3 /41.0 |
6 /6 |
TRYP_PIG TRYPSIN | |
1xxf[4] | E |
NA
SODIUM ION[1 atoms] |
B | 80.0 /42.4 |
5 /5 |
FA11_HUMAN Coagulation factor XI | |
1xxf[1] | F |
NA
SODIUM ION[1 atoms] |
B | 40.0 /42.4 |
5 /5 |
FA11_HUMAN Coagulation factor XI | |
3nps[1] | K |
NA
SODIUM ION[1 atoms] |
A | 100.0 /39.6 |
5 /5 |
ST14_HUMAN Suppressor of tumorigenicity 14 protein | |
6ts4[1] | J |
NA
SODIUM ION[1 atoms] |
A | 50.0 /41.0 |
4 /4 |
FA11_HUMAN Coagulation factor XI | |
7e50[1] | D |
NA
SODIUM ION[1 atoms] |
B | 42.9 /40.3 |
7 /7 |
PLMN_HUMAN Plasminogen | |
7e50[1] | E |
NA
SODIUM ION[1 atoms] |
B | 75.0 /40.3 |
4 /4 |
PLMN_HUMAN Plasminogen | |
1dlk[1] | G |
CL
CHLORIDE ION[1 atoms] |
B | 0.0 /44.7 |
1 /1 |
CTRA_BOVIN Thrombin heavy chain | |
1dlk[1] | G |
CL
CHLORIDE ION[1 atoms] |
D | 0.0 /44.7 |
1 /1 |
CTRA_BOVIN Thrombin heavy chain | |
1o2s[15] | C |
CL
CHLORIDE ION[1 atoms] |
A | 50.0 /40.7 |
2 /2 |
TRY1_BOVIN BETA-TRYPSIN | |
2f91[2] | I |
CL
CHLORIDE ION[1 atoms] |
A | 0.0 /41.6 |
1 /1 |
Q52V24_PONLE hepatopancreas trypsin | |
3dfj[5] | B |
CL
CHLORIDE ION[1 atoms] |
A | 50.0 /43.1 |
2 /2 |
PRSS8_HUMAN Prostasin | |
3dfj[2] | C |
CL
CHLORIDE ION[1 atoms] |
A | 25.0 /43.1 |
4 /5 |
PRSS8_HUMAN Prostasin | |
4abg[1] | C |
CL
CHLORIDE ION[1 atoms] |
A | 0.0 /40.7 |
4 /4 |
TRY1_BOVIN CATIONIC TRYPSIN | |
4crf[1] | J |
CL
CHLORIDE ION[1 atoms] |
A | 50.0 /41.9 |
4 /5 |
FA11_HUMAN Coagulation factor XIa light chain | |
4dur[2] | G |
CL
CHLORIDE ION[1 atoms] |
A | 33.3 /41.3 |
3 /4 |
PLMN_HUMAN Plasminogen | |
4dur[1] | H |
CL
CHLORIDE ION[1 atoms] |
A | 0.0 /41.3 |
5 /5 |
PLMN_HUMAN Plasminogen | |
8g1v[1] | F |
CL
CHLORIDE ION[1 atoms] |
A | 0.0 /39.6 |
3 /3 |
ST14_HUMAN Suppressor of tumorigenicity 14 protein | |
8g1v[1] | H |
CL
CHLORIDE ION[1 atoms] |
A | 0.0 /39.6 |
4 /4 |
ST14_HUMAN Suppressor of tumorigenicity 14 protein | |
8g1v[1] | J |
CL
CHLORIDE ION[1 atoms] |
A | 0.0 /39.6 |
2 /2 |
ST14_HUMAN Suppressor of tumorigenicity 14 protein | |
6aod[1] | O |
CO
COBALT (II) ION[1 atoms] |
C | 0.0 /39.6 |
1 /1 |
FA11_HUMAN Coagulation factor XI | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
OTHERPOLY | |||||||
437 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
1fiw[1] | C | alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(.. | A | 33.3 /46.9 |
6 /6 |
ACRO_SHEEP BETA-ACROSIN HEAVY CHAIN | |
1fiz[2] | C | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-alp.. | A | 33.3 /45.1 |
6 /6 |
ACRO_PIG BETA-ACROSIN HEAVY CHAIN | |
6kd5[1] | E | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 50.0 /45.4 |
4 /5 |
TMPSD_HUMAN Transmembrane protease serine 13 | |
7meq[1] | B | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 33.3 /42.0 |
3 /3 |
TMPS2_HUMAN Transmembrane protease serine 2 | |
8vgt[1] | C | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 0.0 /41.0 |
1 /2 |
TMPS2_HUMAN Transmembrane protease serine 2 | |
2f9n[2] | I | alpha-L-fucopyranose-(1-3)-[2-acetamido-2-deoxy-be.. | B | 0.0 /39.1 |
1 /1 |
TRYA1_HUMAN alpha I tryptase | |
2f9o[2] | E | alpha-L-fucopyranose-(1-3)-[2-acetamido-2-deoxy-be.. | B | 0.0 /38.7 |
1 /1 |
TRYA1_HUMAN Tryptase alpha-1 | |
2f9p[1] | I | alpha-L-fucopyranose-(1-3)-2-acetamido-2-deoxy-bet.. | G | 0.0 /38.7 |
1 /1 |
Tryptase alpha-1 | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
HOMO | |||||||
437 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
5gvt[1] | B | KLKB1_MOUSE Plasma kallikrein[225 aa] | A | 25.0 /45.9 |
12 /13 |
KLKB1_MOUSE Plasma kallikrein | |
5gvt[1] | A | KLKB1_MOUSE Plasma kallikrein[236 aa] | B | 0.0 /46.2 |
8 /9 |
KLKB1_MOUSE Plasma kallikrein | |
6a8o[2] | B | KLKB1_MOUSE Plasma kallikrein[236 aa] | A | 33.3 /45.9 |
3 /5 |
KLKB1_MOUSE Plasma kallikrein | |
1dlk[2] | D | CTRA_BOVIN Thrombin heavy chain[230 aa] | B | 21.1 /44.7 |
19 /23 |
CTRA_BOVIN Thrombin heavy chain | |
1gcd[36] | A | CTRA_BOVIN GAMMA-CHYMOTRYPSIN[237 aa] | A | 23.5 /45.3 |
17 /19 |
CTRA_BOVIN GAMMA-CHYMOTRYPSIN | |
2cga[1] | B | CTRA_BOVIN CHYMOTRYPSINOGEN A[245 aa] | A | 50.0 /44.9 |
4 /8 |
CTRA_BOVIN CHYMOTRYPSINOGEN A | |
2cga[1] | A | CTRA_BOVIN CHYMOTRYPSINOGEN A[245 aa] | B | 40.0 /44.9 |
5 /6 |
CTRA_BOVIN CHYMOTRYPSINOGEN A | |
4q2k[2] | D | CTRA_BOVIN Chymotrypsinogen A[232 aa] | A | 33.3 /46.1 |
3 /3 |
CTRA_BOVIN Chymotrypsinogen A | |
1fiz[2] | A | ACRO_PIG BETA-ACROSIN HEAVY CHAIN[263 aa] | A | 66.7 /45.1 |
3 /8 |
ACRO_PIG BETA-ACROSIN HEAVY CHAIN | |
8y8b[1] | C | TMPS2_HUMAN Transmembrane protease serine 2[47 aa] | D | 35.3 /44.2 |
17 /18 |
TMPS2_HUMAN Transmembrane protease serine 2 | |
3bg8[15] | A | FA11_HUMAN Coagulation factor XIa light chain[238 aa] | A | 0.0 /41.9 |
7 /10 |
FA11_HUMAN Coagulation factor XIa light chain | |
3bg8[15] | A | FA11_HUMAN Coagulation factor XIa light chain[238 aa] | A | 25.0 /41.9 |
8 /8 |
FA11_HUMAN Coagulation factor XIa light chain | |
4cr5[4] | A | FA11_HUMAN COAGULATION FACTOR XIA[238 aa] | A | 14.3 /41.9 |
7 /9 |
FA11_HUMAN COAGULATION FACTOR XIA | |
6twb[1] | B | FA11_HUMAN Coagulation factor XI[8 aa] | A | 66.7 /41.9 |
6 /10 |
FA11_HUMAN Coagulation factor XI | |
8y1e[4] | F | TMPS2_HUMAN Transmembrane protease serine 2[345 aa] | D | 0.0 /41.8 |
2 /2 |
TMPS2_HUMAN Transmembrane protease serine 2 | |
3myw[2] | C | TRYP_PIG Trypsin[223 aa] | A | 20.0 /41.5 |
5 /5 |
TRYP_PIG Trypsin | |
2ptc[4] | A | TRY1_BOVIN BETA-TRYPSIN[223 aa] | A | 33.3 /40.7 |
3 /4 |
TRY1_BOVIN BETA-TRYPSIN | |
1bml[2] | B | PLMN_HUMAN PLASMIN[250 aa] | A | 25.0 /40.3 |
4 /4 |
PLMN_HUMAN PLASMIN | |
1bui[1] | B | PLMN_HUMAN Plasminogen[248 aa] | A | 33.3 /40.3 |
6 /6 |
PLMN_HUMAN Plasminogen | |
1bui[1] | A | PLMN_HUMAN Plasminogen[247 aa] | B | 50.0 /40.3 |
8 /9 |
PLMN_HUMAN Plasminogen | |
1l4d[2] | A | PLMN_HUMAN PLASMINOGEN[249 aa] | A | 40.0 /40.3 |
5 /5 |
PLMN_HUMAN PLASMINOGEN | |
1l4z[2] | A | PLMN_HUMAN Plasminogen[248 aa] | A | 42.1 /40.3 |
19 /19 |
PLMN_HUMAN Plasminogen | |
1rjx[27] | A | PLMN_HUMAN Plasminogen[243 aa] | A | 50.0 /40.6 |
18 /18 |
PLMN_HUMAN Plasminogen | |
1rjx[24] | A | PLMN_HUMAN Plasminogen[243 aa] | A | 14.3 /40.6 |
7 /7 |
PLMN_HUMAN Plasminogen | |
1rjx[24] | A | PLMN_HUMAN Plasminogen[243 aa] | A | 42.9 /40.6 |
7 /10 |
PLMN_HUMAN Plasminogen | |
1rjx[6] | A | PLMN_HUMAN Plasminogen[243 aa] | A | 100.0 /40.6 |
2 /4 |
PLMN_HUMAN Plasminogen | |
1rjx[6] | A | PLMN_HUMAN Plasminogen[243 aa] | A | 28.6 /40.6 |
14 /16 |
PLMN_HUMAN Plasminogen | |
1rjx[27] | A | PLMN_HUMAN Plasminogen[243 aa] | A | 15.0 /40.6 |
20 /20 |
PLMN_HUMAN Plasminogen | |
1and[4] | A | TRY2_RAT ANIONIC TRYPSIN[223 aa] | A | 50.0 /40.4 |
8 /8 |
TRY2_RAT ANIONIC TRYPSIN | |
1a0j[3] | A | TRY3_SALSA TRYPSIN[223 aa] | B | 26.7 /40.2 |
15 /15 |
TRY3_SALSA TRYPSIN | |
1a0j[2] | C | TRY3_SALSA TRYPSIN[223 aa] | B | 22.2 /40.2 |
9 /9 |
TRY3_SALSA TRYPSIN | |
1a0j[4] | D | TRY3_SALSA TRYPSIN[223 aa] | B | 50.0 /40.2 |
4 /4 |
TRY3_SALSA TRYPSIN | |
1a0j[1] | B | TRY3_SALSA TRYPSIN[223 aa] | C | 25.0 /40.2 |
8 /9 |
TRY3_SALSA TRYPSIN | |
1a0j[1] | A | TRY3_SALSA TRYPSIN[223 aa] | D | 0.0 /40.2 |
2 /4 |
TRY3_SALSA TRYPSIN | |
1a0j[1] | C | TRY3_SALSA TRYPSIN[223 aa] | D | 14.3 /40.2 |
7 /7 |
TRY3_SALSA TRYPSIN | |
4is5[2] | A | ST14_HUMAN Suppressor of tumorigenicity 14 protein[241 aa] | A | 12.5 /39.6 |
8 /9 |
ST14_HUMAN Suppressor of tumorigenicity 14 protein | |
7pzo[2] | B | A0A6P6YAT6_DERPT mite allergen Der p 3[230 aa] | A | 13.3 /39.4 |
15 /15 |
A0A6P6YAT6_DERPT mite allergen Der p 3 | |
2f9n[12] | B | TRYA1_HUMAN alpha I tryptase[243 aa] | A | 10.0 /39.1 |
10 /11 |
TRYA1_HUMAN alpha I tryptase | |
2f9n[12] | D | TRYA1_HUMAN alpha I tryptase[243 aa] | A | 21.7 /39.1 |
23 /27 |
TRYA1_HUMAN alpha I tryptase | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
PRECIPITANT | |||||||
437 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
2any[1] | C |
PO4
PHOSPHATE ION[5 atoms] |
A | 0.0 /43.2 |
3 /4 |
KLKB1_HUMAN plasma kallikrein, light chain | |
2any[2] | D |
PO4
PHOSPHATE ION[5 atoms] |
A | 25.0 /43.2 |
4 /4 |
KLKB1_HUMAN plasma kallikrein, light chain | |
5tjx[1] | C |
PO4
PHOSPHATE ION[5 atoms] |
A | 60.0 /44.2 |
5 /5 |
KLKB1_HUMAN Plasma kallikrein | |
5tjx[2] | D |
PO4
PHOSPHATE ION[5 atoms] |
A | 25.0 /44.2 |
4 /4 |
KLKB1_HUMAN Plasma kallikrein | |
6aod[1] | P |
PO4
PHOSPHATE ION[5 atoms] |
C | 0.0 /39.6 |
3 /3 |
FA11_HUMAN Coagulation factor XI | |
6aod[1] | Q |
PO4
PHOSPHATE ION[5 atoms] |
C | 0.0 /39.6 |
1 /2 |
FA11_HUMAN Coagulation factor XI | |
6aod[1] | R |
PO4
PHOSPHATE ION[5 atoms] |
C | 0.0 /39.6 |
2 /2 |
FA11_HUMAN Coagulation factor XI | |
6aod[1] | S |
PO4
PHOSPHATE ION[5 atoms] |
C | 50.0 /39.6 |
2 /2 |
FA11_HUMAN Coagulation factor XI | |
7n7x[1] | C |
PO4
PHOSPHATE ION[5 atoms] |
A | 75.0 /44.2 |
4 /4 |
KLKB1_HUMAN Plasma kallikrein light chain | |
3fp6[1] | J |
PG4
TETRAETHYLENE GLYCOL[13 atoms] |
A | 66.7 /40.4 |
6 /6 |
TRY2_RAT Anionic trypsin-2 | |
4isl[2] | C |
PG4
TETRAETHYLENE GLYCOL[13 atoms] |
B | 0.0 /39.6 |
2 /2 |
ST14_HUMAN Suppressor of tumorigenicity 14 protein | |
8v04[1] | N |
PG4
TETRAETHYLENE GLYCOL[13 atoms] |
B | 66.7 /44.2 |
6 /7 |
TMPS2_HUMAN Transmembrane protease serine 2 | |
8v1f[1] | BA |
PG4
TETRAETHYLENE GLYCOL[13 atoms] |
D | 0.0 /44.2 |
1 /2 |
TMPS2_HUMAN Transmembrane protease serine 2 | |
8v1f[1] | JA |
PG4
TETRAETHYLENE GLYCOL[13 atoms] |
D | 36.4 /44.2 |
11 /11 |
TMPS2_HUMAN Transmembrane protease serine 2 | |
3sor[8] | B |
CIT
CITRIC ACID[13 atoms] |
A | 25.0 /41.5 |
4 /4 |
FA11_HUMAN Coagulation factor XI | |
4x6p[1] | E |
CIT
CITRIC ACID[13 atoms] |
A | 20.0 /41.5 |
5 /5 |
FA11_HUMAN Coagulation factor XI, light chain | |
7v10[9] | C |
CIT
CITRIC ACID[13 atoms] |
A | 42.9 /41.5 |
7 /7 |
FA11_HUMAN Coagulation factor XIa light chain | |
8v04[1] | I |
CIT
CITRIC ACID[13 atoms] |
B | 33.3 /44.2 |
3 /3 |
TMPS2_HUMAN Transmembrane protease serine 2 | |
1fmg[381] | D |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 0.0 /40.6 |
3 /3 |
TRYP_PIG TRYPSIN | |
1fn6[1] | E |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 0.0 /40.6 |
1 /1 |
TRYP_PIG TRYPSIN | |
1s6f[3] | J |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 0.0 /41.0 |
2 /2 |
TRYP_PIG Trypsin | |
1s6f[4] | K |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 0.0 /41.0 |
2 /4 |
TRYP_PIG Trypsin | |
1s82[3] | G |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 0.0 /41.0 |
2 /2 |
TRYP_PIG TRYPSIN | |
3bn9[19] | G |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 20.0 /39.6 |
5 /5 |
ST14_HUMAN Membrane-type serine protease 1 | |
3nps[3] | G |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 0.0 /39.6 |
1 /1 |
ST14_HUMAN Suppressor of tumorigenicity 14 protein | |
4ty6[22] | K |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 22.2 /41.9 |
9 /9 |
FA11_HUMAN Coagulation factor XI | |
4y8x[17] | K |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 33.3 /41.9 |
3 /5 |
FA11_HUMAN Coagulation factor XIa | |
5qcm[3] | F |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 0.0 /41.9 |
2 /2 |
FA11_HUMAN Coagulation factor XI | |
1s5s[89] | E |
GOL
GLYCEROL[6 atoms] |
A | 0.0 /41.0 |
4 /4 |
TRYP_PIG Trypsin | |
1y5a[2] | G |
GOL
GLYCEROL[6 atoms] |
A | 0.0 /39.2 |
4 /4 |
TRY1_BOVIN Trypsin, cationic | |
2zft[3] | G |
GOL
GLYCEROL[6 atoms] |
A | 33.3 /40.7 |
3 /3 |
TRY1_BOVIN Cationic trypsin | |
2zft[1] | H |
GOL
GLYCEROL[6 atoms] |
A | 33.3 /40.7 |
3 /5 |
TRY1_BOVIN Cationic trypsin | |
3a8b[1] | F |
GOL
GLYCEROL[6 atoms] |
A | 33.3 /40.7 |
3 /5 |
TRY1_BOVIN Cationic trypsin | |
3a8b[1] | G |
GOL
GLYCEROL[6 atoms] |
A | 0.0 /40.7 |
5 /5 |
TRY1_BOVIN Cationic trypsin | |
3a8b[1] | J |
GOL
GLYCEROL[6 atoms] |
A | 0.0 /40.7 |
4 /4 |
TRY1_BOVIN Cationic trypsin | |
3a8b[4] | K |
GOL
GLYCEROL[6 atoms] |
A | 50.0 /40.7 |
2 /2 |
TRY1_BOVIN Cationic trypsin | |
3a8d[2] | C |
GOL
GLYCEROL[6 atoms] |
A | 0.0 /40.7 |
6 /6 |
TRY1_BOVIN Cationic trypsin | |
3a8d[1] | D |
GOL
GLYCEROL[6 atoms] |
A | 0.0 /40.7 |
1 /1 |
TRY1_BOVIN Cationic trypsin | |
3a8d[3] | G |
GOL
GLYCEROL[6 atoms] |
A | 50.0 /40.7 |
4 /4 |
TRY1_BOVIN Cationic trypsin | |
3e0p[2] | C |
GOL
GLYCEROL[6 atoms] |
A | 0.0 /42.7 |
1 /1 |
PRSS8_HUMAN Prostasin | |
3gyl[1] | C |
GOL
GLYCEROL[6 atoms] |
A | 0.0 /42.7 |
5 /5 |
PRSS8_HUMAN Prostasin | |
4abi[3] | L |
GOL
GLYCEROL[6 atoms] |
A | 33.3 /40.7 |
3 /3 |
TRY1_BOVIN CATIONIC TRYPSIN | |
4is5[2] | D |
GOL
GLYCEROL[6 atoms] |
A | 81.8 /39.6 |
11 /11 |
ST14_HUMAN Suppressor of tumorigenicity 14 protein | |
4x6p[1] | L |
GOL
GLYCEROL[6 atoms] |
B | 50.0 /41.5 |
4 /6 |
FA11_HUMAN Coagulation factor XI, light chain | |
4x6p[1] | M |
GOL
GLYCEROL[6 atoms] |
B | 12.5 /41.5 |
8 /8 |
FA11_HUMAN Coagulation factor XI, light chain | |
6aod[1] | W |
GOL
GLYCEROL[6 atoms] |
C | 0.0 /39.6 |
1 /1 |
FA11_HUMAN Coagulation factor XI | |
6d3y[1] | D |
GOL
GLYCEROL[6 atoms] |
A | 100.0 /40.3 |
3 /3 |
PLMN_HUMAN Plasminogen | |
6zov[1] | P |
GOL
GLYCEROL[6 atoms] |
D | 20.0 /39.5 |
5 /5 |
ENTK_HUMAN Enteropeptidase | |
7e50[1] | C |
GOL
GLYCEROL[6 atoms] |
B | 75.0 /40.3 |
4 /4 |
PLMN_HUMAN Plasminogen | |
8f7u[2] | J |
GOL
GLYCEROL[6 atoms] |
B | 0.0 /40.3 |
6 /6 |
PLMN_HUMAN Activation peptide | |
8vis[1] | J |
GOL
GLYCEROL[6 atoms] |
B | 0.0 /43.7 |
2 /3 |
TM11D_HUMAN Transmembrane protease serine 11D catalytic chain | |
8vis[1] | L |
GOL
GLYCEROL[6 atoms] |
D | 66.7 /43.7 |
6 /6 |
TM11D_HUMAN Transmembrane protease serine 11D catalytic chain | |
1qqu[2] | C |
ACT
ACETATE ION[4 atoms] |
A | 80.0 /40.6 |
5 /5 |
TRYP_PIG BETA TRYPSIN | |
6i44[1] | BA |
ACT
ACETATE ION[4 atoms] |
A | 66.7 /43.1 |
3 /3 |
KLKB1_HUMAN Plasma kallikrein | |
1y5u[2] | H |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
A | 33.3 /39.2 |
3 /6 |
TRY1_BOVIN Trypsin, cationic | |
4iso[1] | G |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
A | 37.5 /40.1 |
8 /10 |
ST14_HUMAN Suppressor of tumorigenicity 14 protein | |
4iso[1] | I |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
A | 0.0 /40.1 |
3 /3 |
ST14_HUMAN Suppressor of tumorigenicity 14 protein | |
6i44[1] | I |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
A | 25.0 /43.1 |
4 /5 |
KLKB1_HUMAN Plasma kallikrein | |
3ncl[1] | C |
FMT
FORMIC ACID[3 atoms] |
A | 0.0 /39.6 |
1 /1 |
ST14_HUMAN Suppressor of tumorigenicity 14 protein | |
3ncl[1] | D |
FMT
FORMIC ACID[3 atoms] |
A | 66.7 /39.6 |
6 /6 |
ST14_HUMAN Suppressor of tumorigenicity 14 protein | |
3ncl[1] | E |
FMT
FORMIC ACID[3 atoms] |
A | 0.0 /39.6 |
2 /2 |
ST14_HUMAN Suppressor of tumorigenicity 14 protein | |
6i44[1] | Q |
FMT
FORMIC ACID[3 atoms] |
A | 66.7 /43.1 |
3 /3 |
KLKB1_HUMAN Plasma kallikrein | |
6i44[1] | T |
FMT
FORMIC ACID[3 atoms] |
A | 60.0 /43.1 |
5 /5 |
KLKB1_HUMAN Plasma kallikrein | |
6i44[1] | CA |
GLY
GLYCINE[5 atoms] |
A | 0.0 /43.1 |
1 /5 |
KLKB1_HUMAN Plasma kallikrein | |
8a3q[1] | B |
UNL
UNKNOWN LIGAND[36 atoms] |
A | 63.2 /42.8 |
19 /20 |
KLKB1_HUMAN Plasma kallikrein | |
8a3q[1] | C |
MES
2-(N-MORPHOLINO)-ETHANESULFONIC ACID[12 atoms] |
A | 33.3 /42.8 |
6 /7 |
KLKB1_HUMAN Plasma kallikrein | |
6twc[1] | D |
ACN
ACETONE[4 atoms] |
A | 0.0 /41.9 |
2 /2 |
FA11_HUMAN Coagulation factor XI | |
6twc[1] | E |
ACN
ACETONE[4 atoms] |
A | 66.7 /41.9 |
3 /3 |
FA11_HUMAN Coagulation factor XI | |
1p2q[3] | H |
TRS
2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL[8 atoms] |
A | 50.0 /45.1 |
6 /6 |
CTRA_BOVIN Chymotrypsinogen A | |
1zmj[1] | E |
TRS
2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL[8 atoms] |
A | 0.0 /41.9 |
5 /5 |
FA11_HUMAN Coagulation factor XI | |
3sos[1] | C |
TRS
2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL[8 atoms] |
A | 36.4 /41.5 |
11 /11 |
FA11_HUMAN Coagulation factor XI | |
8bo7[1] | D |
TRS
2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL[8 atoms] |
A | 20.0 /41.5 |
5 /5 |
FA11_HUMAN Coagulation factor XIa light chain | |
2zft[5] | D |
DMS
DIMETHYL SULFOXIDE[4 atoms] |
A | 33.3 /40.7 |
3 /6 |
TRY1_BOVIN Cationic trypsin | |
3e16[2] | D |
DMS
DIMETHYL SULFOXIDE[4 atoms] |
A | 75.0 /42.7 |
4 /4 |
PRSS8_HUMAN Prostasin | |
3fvf[1] | D |
DMS
DIMETHYL SULFOXIDE[4 atoms] |
A | 42.9 /42.7 |
7 /7 |
PRSS8_HUMAN Prostasin | |
3fvf[1] | E |
DMS
DIMETHYL SULFOXIDE[4 atoms] |
A | 0.0 /42.7 |
1 /2 |
PRSS8_HUMAN Prostasin | |
4ab9[1] | H |
DMS
DIMETHYL SULFOXIDE[4 atoms] |
A | 0.0 /40.7 |
3 /3 |
TRY1_BOVIN CATIONIC TRYPSIN | |
4abd[1] | I |
DMS
DIMETHYL SULFOXIDE[4 atoms] |
A | 100.0 /40.7 |
2 /3 |
TRY1_BOVIN CATIONIC TRYPSIN | |
6t7p[3] | C |
DMS
DIMETHYL SULFOXIDE[4 atoms] |
A | 25.0 /43.2 |
4 /4 |
KLKB1_HUMAN Plasma kallikrein | |
6t7p[1] | F |
DMS
DIMETHYL SULFOXIDE[4 atoms] |
A | 40.0 /43.2 |
5 /6 |
KLKB1_HUMAN Plasma kallikrein | |
6t7p[1] | I |
DMS
DIMETHYL SULFOXIDE[4 atoms] |
A | 0.0 /43.2 |
4 /4 |
KLKB1_HUMAN Plasma kallikrein | |
6t7p[1] | J |
DMS
DIMETHYL SULFOXIDE[4 atoms] |
A | 60.0 /43.2 |
5 /5 |
KLKB1_HUMAN Plasma kallikrein | |
6t7p[1] | K |
DMS
DIMETHYL SULFOXIDE[4 atoms] |
A | 20.0 /43.2 |
5 /5 |
KLKB1_HUMAN Plasma kallikrein | |
6t7p[3] | L |
DMS
DIMETHYL SULFOXIDE[4 atoms] |
A | 0.0 /43.2 |
3 /3 |
KLKB1_HUMAN Plasma kallikrein | |
6ts4[2] | E |
DMS
DIMETHYL SULFOXIDE[4 atoms] |
A | 0.0 /41.0 |
4 /4 |
FA11_HUMAN Coagulation factor XI | |
6ts4[2] | F |
DMS
DIMETHYL SULFOXIDE[4 atoms] |
A | 20.0 /41.0 |
5 /5 |
FA11_HUMAN Coagulation factor XI | |
6ts4[1] | G |
DMS
DIMETHYL SULFOXIDE[4 atoms] |
A | 33.3 /41.0 |
3 /3 |
FA11_HUMAN Coagulation factor XI | |
6ts5[1] | F |
DMS
DIMETHYL SULFOXIDE[4 atoms] |
A | 0.0 /41.5 |
3 /3 |
FA11_HUMAN Coagulation factor XI | |
6ts5[1] | G |
DMS
DIMETHYL SULFOXIDE[4 atoms] |
A | 50.0 /41.5 |
4 /5 |
FA11_HUMAN Coagulation factor XI | |
6vlv[1] | B |
FLC
CITRATE ANION[13 atoms] |
A | 42.9 /41.5 |
7 /7 |
FA11_HUMAN Coagulation factor XIa light chain | |
6vlv[1] | C |
FLC
CITRATE ANION[13 atoms] |
A | 55.6 /41.5 |
9 /9 |
FA11_HUMAN Coagulation factor XIa light chain | |
4doq[1] | K |
P6G
HEXAETHYLENE GLYCOL[19 atoms] |
C | 28.6 /41.3 |
7 /7 |
TRYP_PIG Trypsin | |
1s82[1] | M |
SBE
1,3,2-DIOXABOROLAN-2-OL[6 atoms] |
A | 85.7 /41.0 |
7 /7 |
TRYP_PIG TRYPSIN | |
1s83[1] | F |
4HA
4-HYDROXYBUTAN-1-AMINIUM[6 atoms] |
A | 90.9 /41.0 |
11 /11 |
TRYP_PIG TRYPSIN | |
1utl[1] | D |
MPD
(4S)-2-METHYL-2,4-PENTANEDIOL[8 atoms] |
A | 0.0 /40.5 |
6 /6 |
TRY1_SALSA TRYPSIN I | |
5xwj[2] | F |
MPD
(4S)-2-METHYL-2,4-PENTANEDIOL[8 atoms] |
A | 0.0 /41.0 |
7 /7 |
TRYP_PIG Trypsin | |
2a31[2] | H |
BO4
BORATE ION[3 atoms] |
A | 0.0 /41.0 |
3 /3 |
TRYP_PIG Trypsin | |
1zml[1] | E |
BCT
BICARBONATE ION[4 atoms] |
A | 0.0 /41.9 |
3 /3 |
FA11_HUMAN Coagulation factor XI | |
1zsj[1] | C |
BCT
BICARBONATE ION[4 atoms] |
A | 50.0 /41.9 |
4 /4 |
FA11_HUMAN Coagulation factor XI | |
1zsk[2] | D |
BCT
BICARBONATE ION[4 atoms] |
A | 50.0 /41.9 |
2 /2 |
FA11_HUMAN Coagulation factor XI | |
2fda[1] | B |
BCT
BICARBONATE ION[4 atoms] |
A | 33.3 /41.9 |
3 /3 |
FA11_HUMAN Coagulation factor XI | |
2fda[1] | D |
BCT
BICARBONATE ION[4 atoms] |
A | 0.0 /41.9 |
2 /3 |
FA11_HUMAN Coagulation factor XI | |
4dur[2] | J |
BCT
BICARBONATE ION[4 atoms] |
A | 75.0 /41.3 |
4 /4 |
PLMN_HUMAN Plasminogen | |
7ths[1] | L |
I5Q
(2S)-butane-1,2-diol[6 atoms] |
B | 0.0 /40.9 |
6 /6 |
PLMN_HUMAN Plasminogen | |
1a0j[847] | I |
SO4
SULFATE ION[5 atoms] |
B | 100.0 /40.2 |
4 /4 |
TRY3_SALSA TRYPSIN | |
1a0j[2] | Q |
SO4
SULFATE ION[5 atoms] |
D | 0.0 /40.2 |
1 /1 |
TRY3_SALSA TRYPSIN | |
1rjx[27] | B |
SO4
SULFATE ION[5 atoms] |
A | 0.0 /40.6 |
1 /2 |
PLMN_HUMAN Plasminogen | |
1utk[10] | C |
SO4
SULFATE ION[5 atoms] |
A | 33.3 /40.5 |
6 /7 |
TRY1_SALSA TRYPSIN I | |
1zmj[9] | C |
SO4
SULFATE ION[5 atoms] |
A | 0.0 /41.9 |
1 /1 |
FA11_HUMAN Coagulation factor XI | |
4crd[10] | E |
SO4
SULFATE ION[5 atoms] |
A | 0.0 /41.9 |
1 /1 |
FA11_HUMAN COAGULATION FACTOR XI | |
4doq[1] | H |
SO4
SULFATE ION[5 atoms] |
A | 0.0 /41.4 |
2 /2 |
TRYP_PIG Trypsin | |
4na7[2] | E |
SO4
SULFATE ION[5 atoms] |
A | 33.3 /41.9 |
6 /7 |
FA11_HUMAN Coagulation factor XI | |
5lyo[2] | E |
SO4
SULFATE ION[5 atoms] |
A | 20.0 /39.2 |
5 /6 |
ST14_HUMAN Suppressor of tumorigenicity 14 protein | |
5lyo[2] | F |
SO4
SULFATE ION[5 atoms] |
A | 33.3 /39.2 |
3 /4 |
ST14_HUMAN Suppressor of tumorigenicity 14 protein | |
5lyo[4] | G |
SO4
SULFATE ION[5 atoms] |
A | 0.0 /39.2 |
1 /1 |
ST14_HUMAN Suppressor of tumorigenicity 14 protein | |
7pzo[2] | D |
SO4
SULFATE ION[5 atoms] |
A | 50.0 /39.4 |
2 /2 |
A0A6P6YAT6_DERPT mite allergen Der p 3 | |
7ths[5] | F |
SO4
SULFATE ION[5 atoms] |
A | 50.0 /39.9 |
4 /4 |
PLMN_HUMAN Plasminogen | |
4abi[1] | D |
DMF
DIMETHYLFORMAMIDE[5 atoms] |
A | 0.0 /40.7 |
5 /5 |
TRY1_BOVIN CATIONIC TRYPSIN | |
4abi[1] | E |
DMF
DIMETHYLFORMAMIDE[5 atoms] |
A | 50.0 /40.7 |
2 /3 |
TRY1_BOVIN CATIONIC TRYPSIN | |
4abi[1] | F |
DMF
DIMETHYLFORMAMIDE[5 atoms] |
A | 50.0 /40.7 |
2 /4 |
TRY1_BOVIN CATIONIC TRYPSIN | |
1fn6[1] | F |
MOH
METHANOL[2 atoms] |
A | 100.0 /40.6 |
1 /1 |
TRYP_PIG TRYPSIN | |
7uah[1] | H |
NZ5
(2~{R})-butane-1,2-diol[6 atoms] |
B | 0.0 /40.3 |
6 /6 |
PLMN_HUMAN Plasminogen | |
6n4t[1] | C |
EOH
ETHANOL[3 atoms] |
A | 33.3 /40.1 |
6 /6 |
ST14_HUMAN Suppressor of tumorigenicity 14 protein | |
1y59[1] | E |
IMD
IMIDAZOLE[5 atoms] |
A | 50.0 /39.2 |
6 /6 |
TRY1_BOVIN Trypsin, cationic | |
1y59[1] | F |
IMD
IMIDAZOLE[5 atoms] |
A | 0.0 /39.2 |
2 /2 |
TRY1_BOVIN Trypsin, cationic | |
1y59[4] | G |
IMD
IMIDAZOLE[5 atoms] |
A | 0.0 /39.2 |
4 /4 |
TRY1_BOVIN Trypsin, cationic | |
1y5a[1] | F |
IMD
IMIDAZOLE[5 atoms] |
A | 100.0 /39.2 |
2 /2 |
TRY1_BOVIN Trypsin, cationic | |
3qk1[1] | I |
IMD
IMIDAZOLE[5 atoms] |
A | 66.7 /39.6 |
3 /3 |
TRY1_BOVIN Cationic trypsin | |
4isl[2] | F |
PGE
TRIETHYLENE GLYCOL[10 atoms] |
B | 60.0 /39.6 |
5 /5 |
ST14_HUMAN Suppressor of tumorigenicity 14 protein | |
6zov[1] | F |
PGE
TRIETHYLENE GLYCOL[10 atoms] |
A | 100.0 /39.5 |
1 /3 |
ENTK_HUMAN Enteropeptidase | |
2f9n[8] | K |
BU3
(R,R)-2,3-BUTANEDIOL[6 atoms] |
A | 20.0 /39.1 |
5 /6 |
TRYA1_HUMAN alpha I tryptase | |
2f9n[8] | P |
BU3
(R,R)-2,3-BUTANEDIOL[6 atoms] |
A | 0.0 /39.1 |
1 /1 |
TRYA1_HUMAN alpha I tryptase | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. |